{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:14:56Z","timestamp":1793697296116,"version":"4.5.1"},"reference-count":777,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010564","name":"Deutsches Zentrum f\u00fcr Lungenforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014780","name":"Longfonds","doi-asserted-by":"publisher","award":["P21-14"],"award-info":[{"award-number":["P21-14"]}],"id":[{"id":"10.13039\/501100014780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011758","name":"Ministrstvo za visoko \u0161olstvo, znanost in tehnologijo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016056","name":"Northern Cara Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["512453064"],"award-info":[{"award-number":["512453064"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["RDZG\/001"],"award-info":[{"award-number":["RDZG\/001"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203151\/A\/16\/Z"],"award-info":[{"award-number":["203151\/A\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203151\/Z\/16\/Z"],"award-info":[{"award-number":["203151\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008035","name":"Harvard Stem Cell Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MC_PC_17230"],"award-info":[{"award-number":["MC_PC_17230"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["847462"],"award-info":[{"award-number":["847462"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["2022\/TTW\/01358852"],"award-info":[{"award-number":["2022\/TTW\/01358852"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019899","name":"Kementerian Keuangan Republik Indonesia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["P01HL158505"],"award-info":[{"award-number":["P01HL158505"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["KIM21G0"],"award-info":[{"award-number":["KIM21G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009103","name":"Von Behring Rontgen Foundation","doi-asserted-by":"publisher","award":["71_0011"],"award-info":[{"award-number":["71_0011"]}],"id":[{"id":"10.13039\/100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000889","name":"Multiple Sclerosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000889","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pharmr.2026.100124","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:51:55Z","timestamp":1770191515000},"page":"100124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Regenerative therapeutics for chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6785-0921","authenticated-orcid":false,"given":"Luke","family":"van der Koog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0163-665X","authenticated-orcid":false,"given":"Henry R.D.","family":"Showell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0922-8271","authenticated-orcid":false,"given":"Dyan F.","family":"Nugraha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8601-8206","authenticated-orcid":false,"given":"Mareike","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1969-480X","authenticated-orcid":false,"given":"Ali \u00d6nder","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-6958","authenticated-orcid":false,"given":"Roc\u00edo","family":"Fuentes-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0792-0374","authenticated-orcid":false,"given":"Hoeke","family":"Baarsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-2659","authenticated-orcid":false,"given":"John-Poul","family":"Ng-Blichfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-907X","authenticated-orcid":false,"given":"Barbro N.","family":"Melgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-2409","authenticated-orcid":false,"given":"Antonella F.M.","family":"Dost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9868-9966","authenticated-orcid":false,"given":"Janette K.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy L.S.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene H.","family":"Heijink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7520-0160","authenticated-orcid":false,"given":"Sidrah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8765-4751","authenticated-orcid":false,"given":"Margherita","family":"Paschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-3900","authenticated-orcid":false,"given":"Evalyne M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1481-2769","authenticated-orcid":false,"given":"Wouter L.J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5149-0084","authenticated-orcid":false,"given":"Jill R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Nagelkerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7901-8198","authenticated-orcid":false,"given":"Henderik W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-9538","authenticated-orcid":false,"given":"Carla F.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5595-152X","authenticated-orcid":false,"given":"Reinoud","family":"Gosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.46598","article-title":"Global burden of chronic obstructive pulmonary disease through 2050","volume":"6","author":"Boers","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1164\/rccm.202204-0671PP","article-title":"Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision","volume":"206","author":"Celli","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.pathol.4.110807.092145","article-title":"The pathology of chronic obstructive pulmonary disease","volume":"4","author":"Hogg","year":"2009","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/medicina58060817","article-title":"Senescence: pathogenic driver in chronic obstructive pulmonary disease","volume":"58","author":"Rivas","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"Suppl 5","key":"10.1016\/j.pharmr.2026.100124_bib6","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1513\/AnnalsATS.201602-124AW","article-title":"Is chronic obstructive pulmonary disease an accelerated aging disease?","volume":"13","author":"MacNee","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/pr.56.4.2","article-title":"Mediators of chronic obstructive pulmonary disease","volume":"56","author":"Barnes","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100124_bib8","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1900475","article-title":"Update on the pathogenesis of chronic obstructive pulmonary disease","volume":"381","author":"Agust\u00ed","year":"2019","journal-title":"N Engl J Med"},{"issue":"10159","key":"10.1016\/j.pharmr.2026.100124_bib9","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1164\/rccm.201210-1843CI","article-title":"Chronic bronchitis and chronic obstructive pulmonary disease","volume":"187","author":"Kim","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100124_bib11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1106955","article-title":"Small-airway obstruction and emphysema in chronic obstructive pulmonary disease","volume":"365","author":"McDonough","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12931-019-1017-y","article-title":"The pathology of small airways disease in COPD: historical aspects and future directions","volume":"20","author":"Higham","year":"2019","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1378\/chest.12-1766","article-title":"Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging","volume":"143","author":"Hogg","year":"2013","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00214-2017","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: gold executive summary","volume":"49","author":"Vogelmeier","year":"2017","journal-title":"Eur Respir J"},{"issue":"9589","key":"10.1016\/j.pharmr.2026.100124_bib15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2026.100124_bib16","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2147\/COPD.S106160","article-title":"Acute exacerbation of COPD: is it the \u201cstroke of the lungs\u201d?","volume":"11","author":"Hillas","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"147","key":"10.1016\/j.pharmr.2026.100124_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0103-2017","article-title":"Exacerbations of COPD","volume":"27","author":"Viniol","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib18","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.161.5.9908022","article-title":"Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease","volume":"161","author":"Seemungal","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100124_bib19","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMc2502456","article-title":"Longitudinal changes in airway mucus plugs and FEV1 in COPD","volume":"392","author":"Mettler","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2105\/AJPH.2014.301887","article-title":"Fewer hospitalizations for chronic obstructive pulmonary disease in communities with smoke-free public policies","volume":"104","author":"Hahn","year":"2014","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.NPR.0000000000000180","article-title":"An update on COPD prevention, diagnosis, and management: the 2024 GOLD Report","volume":"49","author":"Patel","year":"2024","journal-title":"Nurse Pract"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.mcna.2018.12.005","article-title":"Chronic obstructive pulmonary disease: evaluation and management","volume":"103","author":"Duffy","year":"2019","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S2213-2600(24)00409-0","article-title":"Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials","volume":"13","author":"Bhatt","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7196\/SAMJnew.8489","article-title":"Non-pharmacological management of chronic obstructive pulmonary disease","volume":"105","author":"Abraham","year":"2015","journal-title":"S Afr Med J"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/resp.12782","article-title":"Non-pharmacological treatments for COPD","volume":"21","author":"Mulhall","year":"2016","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1513\/pats.200707-107ET","article-title":"Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease","volume":"5","author":"Patel","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib27","article-title":"Lung volume reduction surgery for diffuse emphysema","volume":"10","author":"van Agteren","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmr.2026.100124_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/COPD.S506291","article-title":"Single-use flexible bronchoscope in facilitating endobronchial valve treatment in severe emphysema","volume":"20","author":"Sakaguchi","year":"2025","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/17476348.2024.2431522","article-title":"An update on endobronchial valve therapy for severe emphysema: real world data and special indications","volume":"18","author":"Sakaguchi","year":"2024","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00408-024-00777-0","article-title":"Surgical and bronchoscopic lung volume reduction for severe emphysema: a systematic review and network meta-analysis","volume":"203","author":"Yamamoto","year":"2025","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-020-00345-x","article-title":"Progress in the mechanism and targeted drug therapy for COPD","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coph.2021.05.002","article-title":"Repairing damaged lungs using regenerative therapy","volume":"59","author":"Khedoe","year":"2021","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib33","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/thoraxjnl-2018-212630","article-title":"Regenerative pharmacology for COPD: breathing new life into old lungs","volume":"74","author":"Ng-Blichfeldt","year":"2019","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1164\/rccm.201208-1558PP","article-title":"Regenerative medicine for the respiratory system: distant future or tomorrow\u2019s treatment?","volume":"187","author":"Brouwer","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1203983","article-title":"Evidence for adult lung growth in humans","volume":"367","author":"Butler","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-5223(19)36386-X","article-title":"Dilatation, compensatory growth, or both after pneumonectomy during childhood and adolescence. A thirty-year follow-up study","volume":"93","author":"Laros","year":"1987","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.stem.2020.03.009","article-title":"The cellular and physiological basis for lung repair and regeneration: past, present, and future","volume":"26","author":"Basil","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2014.07.012","article-title":"Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function","volume":"15","author":"Hogan","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib39","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1164\/rccm.201207-1151PP","article-title":"Endogenous lung regeneration: potential and limitations","volume":"186","author":"Rock","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib40","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/s41467-024-46469-4","article-title":"Single-cell division tracing and transcriptomics reveal cell types and differentiation paths in the regenerating lung","volume":"15","author":"Martins","year":"2024","journal-title":"Nat Commun"},{"issue":"31","key":"10.1016\/j.pharmr.2026.100124_bib41","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.1073\/pnas.0906850106","article-title":"Basal cells as stem cells of the mouse trachea and human airway epithelium","volume":"106","author":"Rock","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib42","doi-asserted-by":"crossref","first-page":"L643","DOI":"10.1152\/ajplung.00155.2003","article-title":"In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations","volume":"286","author":"Hong","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7718","key":"10.1016\/j.pharmr.2026.100124_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-018-0394-6","article-title":"A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte","volume":"560","author":"Plasschaert","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12931-022-02042-5","article-title":"Roles of airway basal stem cells in lung homeostasis and regenerative medicine","volume":"23","author":"Wu","year":"2022","journal-title":"Respir Res"},{"issue":"7904","key":"10.1016\/j.pharmr.2026.100124_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-022-04552-0","article-title":"Human distal airways contain a multipotent secretory cell that can regenerate alveoli","volume":"604","author":"Basil","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41588-019-0346-6","article-title":"Lung regeneration by multipotent stem cells residing at the bronchioalveolar-duct junction","volume":"51","author":"Liu","year":"2019","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","article-title":"Identification of bronchioalveolar stem cells in normal lung and lung cancer","volume":"121","author":"Kim","year":"2005","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib48","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1172\/JCI68782","article-title":"Type 2 alveolar cells are stem cells in adult lung","volume":"123","author":"Barkauskas","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib49","first-page":"54","article-title":"The development and plasticity of alveolar type 1 cells","volume":"143","author":"Yang","year":"2016","journal-title":"Development"},{"issue":"6380","key":"10.1016\/j.pharmr.2026.100124_bib50","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.aam6603","article-title":"Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells","volume":"359","author":"Nabhan","year":"2018","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib51","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI57673","article-title":"Integrin \u03b16\u03b24 identifies an adult distal lung epithelial population with regenerative potential in mice","volume":"121","author":"Chapman","year":"2011","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib52","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04168-2020","article-title":"Identification of a novel subset of alveolar type 2 cells enriched in PD-L1 and expanded following pneumonectomy","volume":"58","author":"Ahmadvand","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2026.100124_bib53","article-title":"Differentiation of club cells to alveolar epithelial cells in vitro","volume":"7","author":"Zheng","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.stem.2019.12.014","article-title":"Distinct airway epithelial stem cells hide among club cells but mobilize to promote alveolar regeneration","volume":"26","author":"Kathiriya","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib55","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.stem.2024.08.005","article-title":"Alveolar regeneration by airway secretory-cell-derived p63+ progenitors","volume":"31","author":"Lv","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"146","key":"10.1016\/j.pharmr.2026.100124_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0073-2017","article-title":"Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?","volume":"26","author":"Brandsma","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"157","key":"10.1016\/j.pharmr.2026.100124_bib57","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0222-2020","article-title":"Lung regeneration: implications of the diseased niche and ageing","volume":"29","author":"Melo-Narv\u00e1ez","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmr.2026.100124_bib58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.10.005","article-title":"Mitochondria, telomeres and cell senescence: implications for lung ageing and disease","volume":"183","author":"Birch","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12931-017-0547-4","article-title":"Telomere shortening and accelerated aging in COPD: findings from the BODE cohort","volume":"18","author":"C\u00f3rdoba-Lan\u00fas","year":"2017","journal-title":"Respir Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib60","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1164\/rccm.200509-1374OC","article-title":"Alveolar cell senescence in patients with pulmonary emphysema","volume":"174","author":"Tsuji","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12931-022-01996-w","article-title":"Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease","volume":"23","author":"Yu","year":"2022","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109092","article-title":"Alveolar epithelial cell fate is maintained in a spatially restricted manner to promote lung regeneration after acute injury","volume":"35","author":"Liberti","year":"2021","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib63","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12931-019-1176-x","article-title":"Wnt signaling regulates trans-differentiation of stem cell like type 2 alveolar epithelial cells to type 1 epithelial cells","volume":"20","author":"Abdelwahab","year":"2019","journal-title":"Respir Res"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100124_bib64","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/cells11132055","article-title":"Impaired alveolar re-epithelialization in pulmonary emphysema","volume":"11","author":"Lin","year":"2022","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100124_bib65","article-title":"Wnt3a-loaded extracellular vesicles promote alveolar epithelial regeneration after lung injury","volume":"10","author":"Gao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.pharmr.2026.100124_bib66","article-title":"Small airway disease as a key factor in COPD: new perspectives and insights","volume":"12","author":"Zhou","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib67","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.cell.2017.07.034","article-title":"Distinct mesenchymal lineages and niches promote epithelial self-renewal and myofibrogenesis in the lung","volume":"170","author":"Zepp","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2026.100124_bib68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fcell.2020.00419","article-title":"Dissecting the niche for alveolar type II cells with alveolar organoids","volume":"8","author":"Liao","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib69","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.biomaterials.2013.12.103","article-title":"Comparative decellularization and recellularization of normal versus emphysematous human lungs","volume":"35","author":"Wagner","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib70","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41467-022-28062-9","article-title":"Characterization of the COPD alveolar niche using single-cell RNA sequencing","volume":"13","author":"Sauler","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/thorax.55.2.114","article-title":"Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations","volume":"55","author":"Bhowmik","year":"2000","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib73","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1164\/ajrccm.153.2.8564092","article-title":"Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma","volume":"153","author":"Keatings","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib74","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s10875-009-9286-8","article-title":"Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD","volume":"29","author":"Sapey","year":"2009","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0010008","article-title":"An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema","volume":"1","author":"Grumelli","year":"2004","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2010.02.004","article-title":"Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function","volume":"50","author":"Eickmeier","year":"2010","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/15412555.2013.770456","article-title":"Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients","volume":"10","author":"Zhang","year":"2013","journal-title":"COPD"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.2005.041822","article-title":"COPD exacerbations. 2: aetiology","volume":"61","author":"Sapey","year":"2006","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.stemcr.2019.02.013","article-title":"IL-1 and TNF\u03b1 contribute to the inflammatory niche to enhance alveolar regeneration","volume":"12","author":"Katsura","year":"2019","journal-title":"Stem Cell Reports"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib80","doi-asserted-by":"crossref","first-page":"L342","DOI":"10.1152\/ajplung.00016.2004","article-title":"Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide","volume":"288","author":"Kida","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2026.100124_bib81","article-title":"CD8 T cell response and its released cytokine IFN-\u03b3 are necessary for lung alveolar epithelial repair during bacterial pneumonia","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100124_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1346491","article-title":"The disruptive effects of COPD exacerbation-associated factors on epithelial repair responses","volume":"15","author":"Kortekaas","year":"2024","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib83","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.4049\/jimmunol.1202437","article-title":"TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury","volume":"190","author":"Patel","year":"2013","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib84","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1084\/jem.192.11.1587","article-title":"Interferon gamma induction of pulmonary emphysema in the adult murine lung","volume":"192","author":"Wang","year":"2000","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib85","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1172\/JCI24858","article-title":"Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema","volume":"115","author":"Ma","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib86","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.stem.2020.10.005","article-title":"Human lung stem cell-based alveolospheres provide insights into SARS-CoV-2-mediated interferon responses and pneumocyte dysfunction","volume":"27","author":"Katsura","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmr.2026.100124_bib87","article-title":"A human organoid model of alveolar regeneration reveals distinct epithelial responses to interferon-gamma. Preprint","author":"Dost","year":"2025","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib88","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1165\/rcmb.2022-0209OC","article-title":"IL-1\u03b2 induces a proinflammatory fibroblast microenvironment that impairs lung progenitors\u2019 function","volume":"68","author":"Ciminieri","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib89","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.stem.2020.06.020","article-title":"Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration","volume":"27","author":"Choi","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"7904","key":"10.1016\/j.pharmr.2026.100124_bib90","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41586-022-04541-3","article-title":"Human distal lung maps and lineage hierarchies reveal a bipotent progenitor","volume":"604","author":"Kadur Lakshminarasimha Murthy","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib91","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.4049\/jimmunol.0900473","article-title":"Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease","volume":"183","author":"Shaykhiev","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib92","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1038\/s41598-021-87720-y","article-title":"Macrophages with reduced expressions of classical M1 and M2 surface markers in human bronchoalveolar lavage fluid exhibit pro-inflammatory gene signatures","volume":"11","author":"Takiguchi","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13888-x","article-title":"Abnormal M1\/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD)","volume":"7","author":"Eapen","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib94","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12931-017-0522-0","article-title":"Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity","volume":"18","author":"Bazzan","year":"2017","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1465-9921-12-34","article-title":"Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD","volume":"12","author":"Kunz","year":"2011","journal-title":"Respir Res"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100124_bib96","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3390\/cells12242771","article-title":"Single-cell sequencing of lung macrophages and monocytes reveals novel therapeutic targets in COPD","volume":"12","author":"Hu","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib97","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.11-2348","article-title":"Defective phagocytosis in airways disease","volume":"141","author":"Donnelly","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib98","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib99","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","article-title":"Biology of lung macrophages in health and disease","volume":"55","author":"Aegerter","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imm.13154","article-title":"Origin and ontogeny of lung macrophages: from mice to humans","volume":"160","author":"Evren","year":"2020","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib101","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib102","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20131199","article-title":"Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF","volume":"210","author":"Guilliams","year":"2013","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib103","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2016.02.017","article-title":"Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages","volume":"44","author":"van de Laar","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib104","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1165\/rcmb.2017-0061OC","article-title":"Cell origin dictates programming of resident versus recruited macrophages during acute lung injury","volume":"57","author":"Mould","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100124_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1325090","article-title":"Monocyte-derived alveolar macrophages are key drivers of smoke-induced lung inflammation and tissue remodeling","volume":"15","author":"Wohnhaas","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib106","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12890-018-0664-y","article-title":"Activation and polarization of circulating monocytes in severe chronic obstructive pulmonary disease","volume":"18","author":"Cornwell","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib107","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1165\/rcmb.2016-0361OC","article-title":"Three unique interstitial macrophages in the murine lung at steady state","volume":"57","author":"Gibbings","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib108","first-page":"1318","article-title":"Developmental origin of lung macrophage diversity","volume":"143","author":"Tan","year":"2016","journal-title":"Development"},{"issue":"6432","key":"10.1016\/j.pharmr.2026.100124_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0964","article-title":"Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches","volume":"363","author":"Chakarov","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib110","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1038\/s41467-019-11843-0","article-title":"Non-classical tissue monocytes and two functionally distinct populations of interstitial macrophages populate the mouse lung","volume":"10","author":"Schyns","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib111","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1038\/s41598-017-07101-2","article-title":"Characterisation of lung macrophage subpopulations in COPD patients and controls","volume":"7","author":"Dewhurst","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib112","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12931-021-01828-3","article-title":"Upregulation of leukocyte immunoglobulin-like receptor B4 on interstitial macrophages in COPD; their possible protective role against emphysema formation","volume":"22","author":"Mitsune","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib113","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2349045","article-title":"Dysregulated functions of lung macrophage populations in COPD","volume":"2018","author":"Kapellos","year":"2018","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib114","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.200608-1113OC","article-title":"Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease","volume":"175","author":"Demedts","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"9823","key":"10.1016\/j.pharmr.2026.100124_bib115","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"Decramer","year":"2012","journal-title":"Lancet"},{"issue":"9795","key":"10.1016\/j.pharmr.2026.100124_bib116","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(11)60988-4","article-title":"New insights into the immunology of chronic obstructive pulmonary disease","volume":"378","author":"Brusselle","year":"2011","journal-title":"Lancet"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmr.2026.100124_bib117","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1164\/ajrccm.152.5.7582312","article-title":"Alveolar inflammation and its relation to emphysema in smokers","volume":"152","author":"Finkelstein","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib118","first-page":"L97","article-title":"Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema","volume":"277","author":"Ofulue","year":"1999","journal-title":"Am J Physiol"},{"issue":"5334","key":"10.1016\/j.pharmr.2026.100124_bib119","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1126\/science.277.5334.2002","article-title":"Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice","volume":"277","author":"Hautamaki","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib120","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/bjp.2008.180","article-title":"The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke","volume":"154","author":"Le Qu\u00e9ment","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"172","key":"10.1016\/j.pharmr.2026.100124_bib121","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0263-2023","article-title":"The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis","volume":"33","author":"Pervizaj-Oruqaj","year":"2024","journal-title":"Eur Respir Rev"},{"issue":"6738","key":"10.1016\/j.pharmr.2026.100124_bib122","doi-asserted-by":"crossref","DOI":"10.1126\/science.adq2509","article-title":"Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelae","volume":"387","author":"Wei","year":"2025","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib123","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000506833","article-title":"Modulation of airway epithelial innate immunity and wound repair by M(GM-CSF) and M(M-CSF) macrophages","volume":"12","author":"van Riet","year":"2020","journal-title":"J Innate Immun"},{"key":"10.1016\/j.pharmr.2026.100124_bib124","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/769214","article-title":"Macrophage heterogeneity in respiratory diseases","volume":"2013","author":"Boorsma","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib125","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/thoraxjnl-2015-207020","article-title":"Pulmonary macrophages: key players in the innate defence of the airways","volume":"70","author":"Byrne","year":"2015","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib126","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/JLB.3HI0620-399RR","article-title":"Advanced age is associated with changes in alveolar macrophages and their responses to the stress of traumatic injury","volume":"112","author":"Boe","year":"2022","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib127","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1096\/fj.201902126R","article-title":"Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage","volume":"34","author":"Rymut","year":"2020","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000354173","article-title":"Innate immunity and chronic obstructive pulmonary disease: a mini-review","volume":"59","author":"Shaykhiev","year":"2013","journal-title":"Gerontology"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib129","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1183\/09031936.00036709","article-title":"Defective macrophage phagocytosis of bacteria in COPD","volume":"35","author":"Taylor","year":"2010","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib130","doi-asserted-by":"crossref","first-page":"L686","DOI":"10.1152\/ajplung.00145.2021","article-title":"Evidence for reprogramming of monocytes into reparative alveolar macrophages in vivo by targeting PDE4b","volume":"321","author":"Rochford","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2026.100124_bib131","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fbioe.2019.00318","article-title":"Vascular niche in lung alveolar development, homeostasis, and regeneration","volume":"7","author":"Mammoto","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib132","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cell.2011.10.003","article-title":"Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization","volume":"147","author":"Ding","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib133","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-023-00295-2","article-title":"Rational engineering of lung alveolar epithelium","volume":"8","author":"Leiby","year":"2023","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib134","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53072","article-title":"Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury","volume":"9","author":"Niethamer","year":"2020","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib135","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2013.12.039","article-title":"Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis","volume":"156","author":"Lee","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib136","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10456-024-09910-2","article-title":"The role of vasculature and angiogenesis in respiratory diseases","volume":"27","author":"Ackermann","year":"2024","journal-title":"Angiogenesis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib137","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1165\/rcmb.2023-0084LE","article-title":"Loss of pulmonary endothelial cells in emphysema impairs support of human alveolar epithelial cell growth","volume":"70","author":"Ravi","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib138","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200938","article-title":"Reversal of emphysema by restoration of pulmonary endothelial cells","volume":"218","author":"Hisata","year":"2021","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib139","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1165\/rcmb.2024-0409OC","article-title":"Pulmonary microvascular endothelial cells support alveolar epithelial growth via bone morphogenetic protein 6 secretion","volume":"73","author":"van der Koog","year":"2025","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ydbio.2007.04.042","article-title":"Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis","volume":"308","author":"Yamamoto","year":"2007","journal-title":"Dev Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib141","first-page":"L908","article-title":"Endothelial dysfunction in pulmonary arteries of patients with mild COPD","volume":"274","author":"Peinado","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmr.2026.100124_bib142","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83835","article-title":"Atf3 defines a population of pulmonary endothelial cells essential for lung regeneration","volume":"12","author":"Niethamer","year":"2023","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib143","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.devcel.2020.01.009","article-title":"Epithelial vegfa specifies a distinct endothelial population in the mouse lung","volume":"52","author":"Vila Ellis","year":"2020","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173446","article-title":"Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema","volume":"12","author":"Doyle","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib145","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/sctm.20-0526","article-title":"Resident interstitial lung fibroblasts and their role in alveolar stem cell niche development, homeostasis, injury, and regeneration","volume":"10","author":"Ushakumary","year":"2021","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib146","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1183\/13993003.01911-2015","article-title":"Interleukin-1\u03b1 drives the dysfunctional cross-talk of the airway epithelium and lung fibroblasts in COPD","volume":"48","author":"Osei","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib147","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1465-9921-11-55","article-title":"Altered fibroblast proteoglycan production in COPD","volume":"11","author":"Hallgren","year":"2010","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib148","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-14-21","article-title":"Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts","volume":"14","author":"Larsson-Callerfelt","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176612","article-title":"Lung fibroblast-derived extracellular vesicles and soluble factors alleviate elastase-induced lung injury","volume":"974","author":"van der Koog","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.pharmr.2026.100124_bib150","first-page":"S12","article-title":"Biology of alveolar type II cells","volume":"11","author":"Mason","year":"2006","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib151","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/imm.13319","article-title":"Stromal-immune cell crosstalk fundamentally alters the lung microenvironment following tissue insult","volume":"163","author":"Worrell","year":"2021","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib152","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/15412550903341471","article-title":"The disruption of the epithelial mesenchymal trophic unit in COPD","volume":"6","author":"Behzad","year":"2009","journal-title":"COPD"},{"issue":"3\u20134","key":"10.1016\/j.pharmr.2026.100124_bib153","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2119\/molmed.2010.00138","article-title":"Contribution of neutrophils to acute lung injury","volume":"17","author":"Grommes","year":"2011","journal-title":"Mol Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib154","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1164\/rccm.201409-1663OE","article-title":"On the tricks alveolar epithelial cells play to make a good lung","volume":"191","author":"Weibel","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1164\/rccm.201511-2219OC","article-title":"Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease","volume":"194","author":"Bhatt","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib156","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/ajt.14103","article-title":"Simultaneously targeting myofibroblast contractility and extracellular matrix cross-linking as a therapeutic concept in airway fibrosis","volume":"17","author":"Lin","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.pharmr.2026.100124_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105598","article-title":"Small airway fibrosis in COPD","volume":"116","author":"Barnes","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib158","doi-asserted-by":"crossref","first-page":"L521","DOI":"10.1152\/ajplung.00105.2022","article-title":"A proteomics approach to identify COPD-related changes in lung fibroblasts","volume":"324","author":"Bekker","year":"2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100124_bib159","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/cells13131129","article-title":"Stimuli-specific senescence of primary human lung fibroblasts modulates alveolar stem cell function","volume":"13","author":"Melo-Narv\u00e1ez","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/mi.2013.77","article-title":"DAMPs activating innate and adaptive immune responses in COPD","volume":"7","author":"Pouwels","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib161","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1164\/rccm.200706-929OC","article-title":"Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms","volume":"178","author":"Togo","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib162","doi-asserted-by":"crossref","first-page":"L266","DOI":"10.1152\/ajplung.00419.2022","article-title":"Small airway fibroblasts from patients with chronic obstructive pulmonary disease exhibit cellular senescence","volume":"326","author":"Wrench","year":"2024","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib163","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1165\/rcmb.2010-0426OC","article-title":"Matrix proteins from smoke-exposed fibroblasts are pro-proliferative","volume":"46","author":"Krimmer","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib164","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12931-023-02314-8","article-title":"Gene expression profiles in mesenchymal stromal cells from bone marrow, adipose tissue and lung tissue of COPD patients and controls","volume":"24","author":"Kruk","year":"2023","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib165","doi-asserted-by":"crossref","first-page":"L641","DOI":"10.1152\/ajplung.00249.2004","article-title":"Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema","volume":"288","author":"Plantier","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0178-y","article-title":"The role of FGF-2 in smoke-induced emphysema and the therapeutic potential of recombinant FGF-2 in patients with COPD","volume":"50","author":"Kim","year":"2018","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib167","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1465-9921-9-83","article-title":"Smad gene expression in pulmonary fibroblasts: indications for defective ECM repair in COPD","volume":"9","author":"Zandvoort","year":"2008","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.645558","article-title":"Harnessing the ECM microenvironment to ameliorate mesenchymal stromal cell-based therapy in chronic lung diseases","volume":"12","author":"Elowsson Rendin","year":"2021","journal-title":"Front Pharmacol"},{"issue":"148","key":"10.1016\/j.pharmr.2026.100124_bib169","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0032-2018","article-title":"The consequence of matrix dysfunction on lung immunity and the microbiome in COPD","volume":"27","author":"Hussell","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib170","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/rccm.200303-371OC","article-title":"Human alveolar wall fibroblasts directly link epithelial type 2 cells to capillary endothelium","volume":"168","author":"Sirianni","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib171","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1440-1843.2010.01808.x","article-title":"Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease","volume":"15","author":"Sohal","year":"2010","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib172","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/path.4808","article-title":"The extracellular matrix \u2013 the under-recognized element in lung disease?","volume":"240","author":"Burgess","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmr.2026.100124_bib173","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.matbio.2018.03.005","article-title":"Extracellular matrix in lung development, homeostasis and disease","volume":"73","author":"Zhou","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.pharmr.2026.100124_bib174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.003","article-title":"Interplay of extracellular matrix and leukocytes in lung inflammation","volume":"312","author":"Wight","year":"2017","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00441-009-0853-3","article-title":"Role of the extracellular matrix in lymphocyte migration","volume":"339","author":"Korpos","year":"2010","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.995051","article-title":"Highway to heal: influence of altered extracellular matrix on infiltrating immune cells during acute and chronic lung diseases","volume":"13","author":"Joglekar","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib177","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/iep.12428","article-title":"Role of extracellular matrix proteoglycans in immune cell recruitment","volume":"103","author":"Gray","year":"2022","journal-title":"Int J Exp Pathol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib178","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00192611","article-title":"Extracellular matrix composition in COPD","volume":"40","author":"Annoni","year":"2012","journal-title":"Eur Respir J"},{"issue":"158","key":"10.1016\/j.pharmr.2026.100124_bib179","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0124-2019","article-title":"Extracellular matrix remodelling in COPD","volume":"29","author":"Karakioulaki","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmr.2026.100124_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107839","article-title":"Therapeutic targets in lung tissue remodelling and fibrosis","volume":"225","author":"Liu","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib181","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0001-37652007000200010","article-title":"The extracellular matrix of the lung and its role in edema formation","volume":"79","author":"Pelosi","year":"2007","journal-title":"An Acad Bras Cienc"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100124_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910613","article-title":"The role of the extracellular matrix in the pathogenesis and treatment of pulmonary emphysema","volume":"25","author":"Cantor","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib183","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00418-018-1747-9","article-title":"The micromechanics of lung alveoli: structure and function of surfactant and tissue components","volume":"150","author":"Knudsen","year":"2018","journal-title":"Histochem Cell Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib184","doi-asserted-by":"crossref","first-page":"L304","DOI":"10.1152\/ajplung.00332.2023","article-title":"The lung extracellular matrix protein landscape in severe early-onset and moderate chronic obstructive pulmonary disease","volume":"327","author":"Joglekar","year":"2024","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"163","key":"10.1016\/j.pharmr.2026.100124_bib185","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0202-2021","article-title":"Chronic lung diseases: entangled in extracellular matrix","volume":"31","author":"Burgess","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib186","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1152\/japplphysiol.01244.2010","article-title":"Lung tissue mechanics as an emergent phenomenon","volume":"110","author":"Suki","year":"2011","journal-title":"J Appl Physiol (1985)"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib187","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/cells8040342","article-title":"Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies?","volume":"8","author":"Ito","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib188","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/thoraxjnl-2020-215114","article-title":"COPD-derived fibroblasts secrete higher levels of senescence-associated secretory phenotype proteins","volume":"76","author":"Woldhuis","year":"2021","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib189","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1081\/COPD-200050678","article-title":"Different modulation of decorin production by lung fibroblasts from patients with mild and severe emphysema","volume":"2","author":"Noordhoek","year":"2005","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1465-9921-7-89","article-title":"Decorin and TGF-beta1 polymorphisms and development of COPD in a general population","volume":"7","author":"van Diemen","year":"2006","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100042","article-title":"Cyclic nucleotide phosphodiesterases as drug targets","volume":"77","author":"Kelly","year":"2025","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2026.100124_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118864","article-title":"Role of \u03b22-adrenergic receptors in chronic obstructive pulmonary disease","volume":"265","author":"Yang","year":"2021","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib193","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pupt.2012.05.007","article-title":"cAMP regulation of airway smooth muscle function","volume":"26","author":"Billington","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib194","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coph.2020.05.002","article-title":"Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases","volume":"51","author":"Schmidt","year":"2020","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib195","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/14740338.2018.1472233","article-title":"The safety of indacaterol for the treatment of COPD","volume":"17","author":"Metaxas","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib196","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s40265-019-01133-w","article-title":"Tiotropium\/olodaterol: a review in COPD","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100124_bib197","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMoa1608033","article-title":"Effectiveness of fluticasone furoate-vilanterol for COPD in clinical practice","volume":"375","author":"Vestbo","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib198","article-title":"Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)","volume":"2","author":"Horita","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib199","first-page":"CD015997","article-title":"Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis","volume":"4","author":"Oba","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"38","key":"10.1016\/j.pharmr.2026.100124_bib200","doi-asserted-by":"crossref","first-page":"32899","DOI":"10.1074\/jbc.R110.206466","article-title":"Biochemical basis of asthma therapy","volume":"286","author":"Barnes","year":"2011","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib201","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/thx.2007.080382","article-title":"In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury","volume":"63","author":"Perkins","year":"2008","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib202","doi-asserted-by":"crossref","first-page":"L1108","DOI":"10.1152\/ajplung.00148.2001","article-title":"Activation of protein kinase A accelerates bovine bronchial epithelial cell migration","volume":"282","author":"Spurzem","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib203","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pharmrev.121.000356","article-title":"Inhaled \u03b22 adrenergic agonists and other cAMP-elevating agents: therapeutics for alveolar injury and acute respiratory disease syndrome?","volume":"73","author":"Sriram","year":"2021","journal-title":"Pharmacol Rev"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib204","doi-asserted-by":"crossref","first-page":"C847","DOI":"10.1152\/ajpcell.00159.2015","article-title":"Agonist binding to \u03b2-adrenergic receptors on human airway epithelial cells inhibits migration and wound repair","volume":"309","author":"Peitzman","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib205","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129259","article-title":"\u03b21 Integrin regulates adult lung alveolar epithelial cell inflammation","volume":"5","author":"Plosa","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib206","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/0022034510388034","article-title":"Adrenergic signaling in human oral keratinocytes and wound repair","volume":"90","author":"Steenhuis","year":"2011","journal-title":"J Dent Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib207","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.phrs.2008.07.012","article-title":"Beta-adrenergic receptor modulation of wound repair","volume":"58","author":"Pullar","year":"2008","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib208","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1167\/iovs.07-0925","article-title":"Beta2-adrenergic receptor signaling mediates corneal epithelial wound repair","volume":"49","author":"Ghoghawala","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6 Suppl","key":"10.1016\/j.pharmr.2026.100124_bib209","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1067\/mai.2002.129704","article-title":"Effect of beta-adrenergic agonists on mucociliary clearance","volume":"110","author":"Bennett","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.rmed.2011.02.007","article-title":"Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD","volume":"105","author":"Meyer","year":"2011","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib211","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200712-1869OC","article-title":"Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study","volume":"178","author":"Celli","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100124_bib212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Fan Chung","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib213","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pupt.2005.11.010","article-title":"Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD","volume":"20","author":"Jones","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib214","article-title":"cAMP-PDE signaling in COPD: review of cellular, molecular and clinical features","volume":"34","author":"Nourian","year":"2023","journal-title":"Biochem Biophys Rep"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib215","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1164\/rccm.201712-2493OC","article-title":"Determinants of response to roflumilast in severe chronic obstructive pulmonary disease. Pooled analysis of two randomized trials","volume":"198","author":"Martinez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib216","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/COPD.S89849","article-title":"Roflumilast: a review of its use in the treatment of COPD","volume":"11","author":"Wedzicha","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"9691","key":"10.1016\/j.pharmr.2026.100124_bib217","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","article-title":"Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials","volume":"374","author":"Calverley","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib218","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.202306-0944OC","article-title":"Ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor for the treatment of chronic obstructive pulmonary disease: randomized, double-blind, placebo-controlled, multicenter phase III trials (the ENHANCE trials)","volume":"208","author":"Anzueto","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100124_bib219","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.3390\/cells13211750","article-title":"Dual inhibition of phosphodiesterase 3 and 4 enzymes by ensifentrine protects against MRSA-induced lung endothelial and epithelial dysfunction","volume":"13","author":"Al Matni","year":"2024","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib220","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.tips.2024.08.002","article-title":"Ensifentrine (Ohtuvayre\u2122) for chronic obstructive pulmonary disease","volume":"45","author":"Hubert","year":"2024","journal-title":"Trends Pharmacol Sci"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100124_bib221","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182111590","article-title":"Modification of apremilast from pills to aerosol a future concept","volume":"18","author":"Zarogoulidis","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib222","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jsps.2023.05.022","article-title":"Effect of apremilast on LPS-induced immunomodulation and inflammation via activation of Nrf2\/HO-1 pathways in rat lungs","volume":"31","author":"Al-Harbi","year":"2023","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.pharmr.2026.100124_bib223","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.740803","article-title":"Tanimilast, a novel inhaled PDE4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease","volume":"12","author":"Facchinetti","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100124_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154739","article-title":"The modulatory effects of the PDE4 inhibitors CHF6001 and roflumilast in alveolar macrophages and lung tissue from COPD patients","volume":"123","author":"Lea","year":"2019","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib225","doi-asserted-by":"crossref","first-page":"L507","DOI":"10.1152\/ajplung.00069.2017","article-title":"The PDE4 inhibitor CHF-6001 and LAMAs inhibit bronchoconstriction-induced remodeling in lung slices","volume":"313","author":"Kistemaker","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib226","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12967-022-03402-x","article-title":"The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation","volume":"20","author":"Nguyen","year":"2022","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib227","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/jpet.114.220541","article-title":"CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration","volume":"352","author":"Moretto","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib228","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3389\/fphar.2019.01337","article-title":"CHF6001 inhibits NF-\u03baB activation and neutrophilic recruitment in LPS-induced lung inflammation in mice","volume":"10","author":"Stellari","year":"2019","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib229","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.114.220558","article-title":"CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration\u2013in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic window","volume":"352","author":"Villetti","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib230","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1378\/chest.15-1029","article-title":"Prostanoids in asthma and COPD: actions, dysregulation, and therapeutic opportunities","volume":"148","author":"Zaslona","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib231","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1378\/chest.08-0306","article-title":"Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?","volume":"133","author":"Huang","year":"2008","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib232","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1164\/rccm.201208-1361OC","article-title":"The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts","volume":"187","author":"Dagouassat","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib233","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1440-1843.2008.01365.x","article-title":"Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD","volume":"13","author":"Chen","year":"2008","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib234","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/thorax.58.7.585","article-title":"Exhaled leukotrienes and prostaglandins in COPD","volume":"58","author":"Montuschi","year":"2003","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib235","doi-asserted-by":"crossref","first-page":"L648","DOI":"10.1152\/ajplung.90270.2008","article-title":"Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema","volume":"296","author":"Chen","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib236","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj9949","article-title":"A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration","volume":"8","author":"Wu","year":"2022","journal-title":"Sci Adv"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib237","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207872","article-title":"Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors","volume":"13","author":"Sieber","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib238","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144799","article-title":"Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions","volume":"6","author":"Fortier","year":"2021","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib239","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/15412555.2018.1537365","article-title":"Adenosine metabolism in COPD: a study on adenosine levels, 5\u2032-nucleotidase, adenosine deaminase and its isoenzymes activity in serum, lymphocytes and erythrocytes","volume":"15","author":"Singh Patidar","year":"2018","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009224","article-title":"Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis","volume":"5","author":"Zhou","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib241","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tips.2009.07.005","article-title":"Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease","volume":"30","author":"Polosa","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib242","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-2999(02)01305-5","article-title":"Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat","volume":"438","author":"Fozard","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib243","doi-asserted-by":"crossref","first-page":"L1335","DOI":"10.1152\/ajplung.00416.2006","article-title":"Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice","volume":"292","author":"Nadeem","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib244","doi-asserted-by":"crossref","first-page":"L753","DOI":"10.1152\/ajplung.00187.2007","article-title":"Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice","volume":"293","author":"Mohsenin","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib245","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/rccm.200506-869OC","article-title":"Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease","volume":"173","author":"Varani","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib246","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1172\/JCI27303","article-title":"Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury","volume":"116","author":"Sun","year":"2006","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib247","doi-asserted-by":"crossref","first-page":"L317","DOI":"10.1152\/ajplung.00118.2005","article-title":"Adenosine induces fibronectin expression in lung epithelial cells: implications for airway remodeling","volume":"290","author":"Roman","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib248","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000482","article-title":"Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern","volume":"2","author":"Selman","year":"2007","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib249","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.106.112250","article-title":"Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma","volume":"320","author":"Mustafa","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib250","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1165\/rcmb.2013-0089OC","article-title":"Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease","volume":"49","author":"Karmouty-Quintana","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib251","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1183\/09031936.00193908","article-title":"Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: torch study results","volume":"34","author":"Crim","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2026.100124_bib252","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/COPD.S42366","article-title":"Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis","volume":"8","author":"Yawn","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib253","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib254","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib255","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00239-2023","article-title":"Global initiative for chronic obstructive lung disease 2023 report: gold executive summary","volume":"61","author":"Agust\u00ed","year":"2023","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib257","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.2010.01199.x","article-title":"Glucocorticosteroids: current and future directions","volume":"163","author":"Barnes","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100124_bib258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2015.11.004","article-title":"Interaction between corticosteroids and muscarinic antagonists in human airways","volume":"36","author":"Cazzola","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100124_bib259","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1111\/febs.16100","article-title":"A guide to changing paradigms of glucocorticoid receptor function-a model system for genome regulation and physiology","volume":"289","author":"Vettorazzi","year":"2022","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib260","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1094-5539(03)00052-X","article-title":"Elastase-induced changes in lung function: relationship to morphometry and effect of drugs","volume":"16","author":"Nishi","year":"2003","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib261","doi-asserted-by":"crossref","first-page":"L794","DOI":"10.1152\/ajplung.00322.2005","article-title":"Effects of corticosteroid-induced apoptosis on airway epithelial wound closure in vitro","volume":"291","author":"Dorscheid","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2026.100124_bib262","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.reth.2023.09.006","article-title":"Lung regeneration with rat fetal lung implantation and promotion of alveolar stem cell differentiation by corticosteroids","volume":"24","author":"Matsumoto","year":"2023","journal-title":"Regen Ther"},{"issue":"35","key":"10.1016\/j.pharmr.2026.100124_bib263","doi-asserted-by":"crossref","first-page":"24917","DOI":"10.1016\/S0021-9258(19)73982-9","article-title":"Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids","volume":"267","author":"Matsumoto","year":"1992","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib264","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1007\/s12325-023-02583-1","article-title":"DElaying Disease Progression in COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): a predictive modelling approach","volume":"40","author":"Singh","year":"2023","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib265","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/15412550902772593","article-title":"The effect of inhaled corticosteroids on the development of emphysema in smokers assessed by annual computed tomography","volume":"6","author":"Shaker","year":"2009","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib266","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1378\/chest.14-3091","article-title":"Relapse in FEV1 decline after steroid withdrawal in COPD","volume":"148","author":"Kunz","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib267","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"141","author":"Yun","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib268","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00408-020-00397-4","article-title":"Benefits and risks of inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease classified by blood eosinophil counts","volume":"198","author":"Saito","year":"2020","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib269","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063430","article-title":"Inhaled steroids modulate extracellular matrix composition in bronchial biopsies of COPD patients: a randomized, controlled trial","volume":"8","author":"Kunz","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/thoraxjnl-2012-202878","article-title":"Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity","volume":"69","author":"van den Berge","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.pharmr.2026.100124_bib271","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fcimb.2020.00278","article-title":"Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells","volume":"10","author":"Wang","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib272","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","article-title":"Airway mucus hypersecretion in asthma: an undervalued pathology?","volume":"4","author":"Rogers","year":"2004","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib273","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.resinv.2024.10.004","article-title":"Efficacy and safety of mucolytics in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"62","author":"Ohnishi","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.pharmr.2026.100124_bib274","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/14983","article-title":"Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease","volume":"2007","author":"Ward","year":"2007","journal-title":"PPAR Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib275","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib276","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clim.2004.09.008","article-title":"15d-PGJ2: the anti-inflammatory prostaglandin?","volume":"114","author":"Scher","year":"2005","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib277","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.2503003","article-title":"Who tidies up the lung? Listen to Cox-2 and Nrf2","volume":"171","author":"Uhlig","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib278","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/COPD.S345796","article-title":"Pioglitazone and risk of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: a retrospective cohort study","volume":"17","author":"Tseng","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2026.100124_bib279","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2147\/COPD.S82643","article-title":"Thiazolidinediones are associated with a reduced risk of COPD exacerbations","volume":"10","author":"Rinne","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1183\/09031936.00187812","article-title":"The effect of peroxisome proliferator-activated receptor-\u03b3 ligands on in vitro and in vivo models of COPD","volume":"43","author":"Lea","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib281","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12964-024-01501-4","article-title":"Harnessing peroxisome proliferator-activated receptor \u03b3 agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disorders","volume":"22","author":"Lee","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib282","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/abbs\/gmq071","article-title":"Positive correlation between PPARgamma\/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease","volume":"42","author":"Li","year":"2010","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib283","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00011-022-01637-4","article-title":"Low 15d-PGJ2 status is associated with oxidative stress in chronic obstructive pulmonary disease patients","volume":"72","author":"Ma","year":"2023","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib284","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.freeradbiomed.2018.08.014","article-title":"Role of GPx3 in PPAR\u03b3-induced protection against COPD-associated oxidative stress","volume":"126","author":"Reddy","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib285","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109293","article-title":"PPAR\u03b3 inhibits small airway remodeling through mediating the polarization homeostasis of alveolar macrophages in COPD","volume":"250","author":"He","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pharmr.2026.100124_bib286","first-page":"715","article-title":"Rosiglitazone attenuates the metalloprotease\/anti-metalloprotease imbalance in emphysema induced by cigarette smoke: involvement of extracellular signal-regulated kinase and NF\u03baB signaling","volume":"10","author":"Hou","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib287","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.21037\/jtd.2017.09.10","article-title":"Peroxisome proliferator-activated receptor-\u03b3 in induced sputum is correlated with MMP-9\/TIMP-1 imbalance and formation of emphysema in COPD patients","volume":"9","author":"Zhou","year":"2017","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib288","doi-asserted-by":"crossref","first-page":"L293","DOI":"10.1152\/ajplung.00287.2014","article-title":"Airway epithelial cell PPAR\u03b3 modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice","volume":"309","author":"Solleti","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib289","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12272-020-01235-0","article-title":"LJ-529, a partial peroxisome proliferator-activated receptor gamma (PPAR\u03b3) agonist and adenosine A3 receptor agonist, ameliorates elastase-induced pulmonary emphysema in mice","volume":"43","author":"Boo","year":"2020","journal-title":"Arch Pharm Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib290","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1165\/rcmb.2023-0290OC","article-title":"Lipid deficiency contributes to impaired alveolar progenitor cell function in aging and idiopathic pulmonary fibrosis","volume":"71","author":"Liang","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib291","first-page":"126","article-title":"The multifaceted nature of retinoid transport and metabolism","volume":"3","author":"Li","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib292","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm3932","article-title":"Mechanisms of retinoic acid signalling and its roles in organ and limb development","volume":"16","author":"Cunningham","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib293","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41467-023-36475-3","article-title":"Retinoids stored locally in the lung are required to attenuate the severity of acute lung injury in male mice","volume":"14","author":"Shmarakov","year":"2023","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib294","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/thx.2007.093302","article-title":"Dysregulation of elastin expression by fibroblasts in pulmonary emphysema: role of cellular retinoic acid binding protein 2","volume":"63","author":"Plantier","year":"2008","journal-title":"Thorax"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmr.2026.100124_bib295","first-page":"L430","article-title":"Retinoic acid increases elastin in neonatal rat lung fibroblast cultures","volume":"265","author":"Liu","year":"1993","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib296","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02639383","article-title":"Rat tracheal epithelial cell differentiation in vitro","volume":"29A","author":"Kaartinen","year":"1993","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.pharmr.2026.100124_bib297","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ebiom.2018.09.002","article-title":"Retinoic acid signaling balances adult distal lung epithelial progenitor cell growth and differentiation","volume":"36","author":"Ng-Blichfeldt","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib298","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/thoraxjnl-2016-208846","article-title":"Deficient retinoid-driven angiogenesis may contribute to failure of adult human lung regeneration in emphysema","volume":"72","author":"Ng-Blichfeldt","year":"2017","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib299","doi-asserted-by":"crossref","first-page":"L529","DOI":"10.1152\/ajplung.00336.2004","article-title":"Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats","volume":"289","author":"Kunig","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib300","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1165\/rcmb.2005-0050OC","article-title":"Retinoic acid and erythropoietin maintain alveolar development in mice treated with an angiogenesis inhibitor","volume":"33","author":"Cho","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib301","doi-asserted-by":"crossref","first-page":"L869","DOI":"10.1152\/ajplung.00109.2019","article-title":"The lipofibroblast: more than a lipid-storage depot","volume":"316","author":"McGowan","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib302","doi-asserted-by":"crossref","first-page":"L431","DOI":"10.1152\/ajplung.00245.2002","article-title":"Retinoic acid receptor-alpha regulates pulmonary alveolus formation in mice after, but not during, perinatal period","volume":"284","author":"Massaro","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib303","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1152\/physiolgenomics.2000.4.1.51","article-title":"Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli","volume":"4","author":"Massaro","year":"2000","journal-title":"Physiol Genomics"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib304","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1165\/ajrcmb.23.2.3904","article-title":"Mice bearing deletions of retinoic acid receptors demonstrate reduced lung elastin and alveolar numbers","volume":"23","author":"McGowan","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100124_bib305","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa0907441","article-title":"Maternal vitamin A supplementation and lung function in offspring","volume":"362","author":"Checkley","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib306","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.201912-2338OC","article-title":"Lung development genes and adult lung function","volume":"202","author":"Portas","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib307","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/ng.941","article-title":"Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function","volume":"43","author":"Soler Artigas","year":"2011","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib308","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/thorax-2024-222622","article-title":"Effect of vitamin A on adult lung function: a triangulation of evidence approach","volume":"80","author":"Mongey","year":"2025","journal-title":"Thorax"},{"key":"10.1016\/j.pharmr.2026.100124_bib309","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.2147\/COPD.S432995","article-title":"The associations between serum vitamins and carotenoids with chronic obstructive pulmonary disease: results from the NHANES","volume":"18","author":"Zheng","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib310","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jn\/130.5.1159","article-title":"Vitamin A deficiency injures lung and liver parenchyma and impairs function of rat type II pneumocytes","volume":"130","author":"Baybutt","year":"2000","journal-title":"J Nutr"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib311","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nm0697-675","article-title":"Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats","volume":"3","author":"Massaro","year":"1997","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib312","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1183\/09031936.03.00119103","article-title":"Retinoic acid induces alveolar regeneration in the adult mouse lung","volume":"23","author":"Hind","year":"2004","journal-title":"Eur Respir J"},{"issue":"5 Suppl 1","key":"10.1016\/j.pharmr.2026.100124_bib313","doi-asserted-by":"crossref","first-page":"242S","DOI":"10.1378\/chest.117.5_suppl_1.242S","article-title":"Can retinoic acid ameliorate the physiologic and morphologic effects of elastase instillation in the rat?","volume":"117","author":"Tepper","year":"2000","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib314","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/thx.2003.010785","article-title":"Retinoic acid fails to reverse emphysema in adult mouse models","volume":"59","author":"Fujita","year":"2004","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib315","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000070068","article-title":"Retinoic acid does not affect alveolar septation in adult FVB mice with elastase-induced emphysema","volume":"70","author":"Lucey","year":"2003","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib316","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1165\/rcmb.2006-0029OC","article-title":"Retinoids have differing efficacies on alveolar regeneration in a dexamethasone-treated mouse","volume":"35","author":"Maden","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib317","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1165\/rcmb.2007-0252OC","article-title":"Retinoic acid induced alveolar regeneration: critical differences in strain sensitivity","volume":"38","author":"Stinchcombe","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib318","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/ajrccm.165.5.2106123","article-title":"A pilot study of all-trans-retinoic acid for the treatment of human emphysema","volume":"165","author":"Mao","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib319","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1378\/chest.130.5.1334","article-title":"Feasibility of retinoids for the treatment of emphysema study","volume":"130","author":"Roth","year":"2006","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib320","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/thoraxjnl-2020-214986","article-title":"Pretreatment of aged mice with retinoic acid supports alveolar regeneration via upregulation of reciprocal PDGFA signalling","volume":"76","author":"Gokey","year":"2021","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib321","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1183\/09031936.00161911","article-title":"Randomised controlled trial for emphysema with a selective agonist of the \u03b3-type retinoic acid receptor","volume":"40","author":"Stolk","year":"2012","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib322","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/acschembio.8b00916","article-title":"Fluorescent retinoic acid analogues as probes for biochemical and intracellular characterization of retinoid signaling pathways","volume":"14","author":"Chisholm","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.pharmr.2026.100124_bib323","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/bs.mie.2020.02.011","article-title":"Design of synthetic retinoids","volume":"637","author":"Chisholm","year":"2020","journal-title":"Methods Enzymol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib324","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jdb8010006","article-title":"Regulating retinoic acid availability during development and regeneration: the role of the CYP26 enzymes","volume":"8","author":"Roberts","year":"2020","journal-title":"J Dev Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib325","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib326","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib327","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.celrep.2016.11.001","article-title":"Emergence of a wave of Wnt signaling that regulates lung alveologenesis by controlling epithelial self-renewal and differentiation","volume":"17","author":"Frank","year":"2016","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib328","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1128\/MCB.22.4.1184-1193.2002","article-title":"Negative feedback loop of Wnt signaling through upregulation of conductin\/axin2 in colorectal and liver tumors","volume":"22","author":"Lustig","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmr.2026.100124_bib329","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109588","article-title":"Chronic WNT\/\u03b2-catenin signaling induces cellular senescence in lung epithelial cells","volume":"70","author":"Lehmann","year":"2020","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib330","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1164\/rccm.200910-1560OC","article-title":"Activation of the WNT\/\u03b2-catenin pathway attenuates experimental emphysema","volume":"183","author":"Kneidinger","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"7836","key":"10.1016\/j.pharmr.2026.100124_bib331","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-020-2882-8","article-title":"Inhibition of LT\u03b2R signalling activates WNT-induced regeneration in lung","volume":"588","author":"Conlon","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib332","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/stem.3241","article-title":"Wnt\/\u03b2-catenin signaling is critical for regenerative potential of distal lung epithelial progenitor cells in homeostasis and emphysema","volume":"38","author":"Hu","year":"2020","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib333","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1465-9921-14-117","article-title":"Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy","volume":"14","author":"Verhees","year":"2013","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib334","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1465-9921-14-113","article-title":"Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology","volume":"14","author":"Baarsma","year":"2013","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib335","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.200609-1292OC","article-title":"Glycogen synthase kinase-3beta inhibition attenuates asthma in mice","volume":"176","author":"Bao","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib336","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025450","article-title":"Activation of WNT\/\u03b2-catenin signaling in pulmonary fibroblasts by TGF-\u03b21 is increased in chronic obstructive pulmonary disease","volume":"6","author":"Baarsma","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100124_bib337","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.2147\/COPD.S327887","article-title":"GSK-3\u03b2 inhibitors attenuate the PM2.5-induced inflammatory response in bronchial epithelial cells","volume":"16","author":"Zou","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib338","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/ijms25021279","article-title":"Glycogen synthase kinase-3 inhibition by CHIR99021 promotes alveolar epithelial cell proliferation and lung regeneration in the lipopolysaccharide-induced acute lung injury mouse model","volume":"25","author":"Fernandes","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib339","article-title":"Glycogen synthase kinase 3 induces multilineage maturation of human pluripotent stem cell-derived lung progenitors in 3D culture","volume":"146","author":"de Carvalho","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.pharmr.2026.100124_bib340","article-title":"Glycogen synthase kinase-3 inhibitors: preclinical and clinical focus on CNS-A decade onward","volume":"14","author":"Arciniegas Ruiz","year":"2021","journal-title":"Front Mol Neurosci"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100124_bib341","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1111\/bph.15581","article-title":"A drug screen with approved compounds identifies amlexanox as a novel Wnt\/\u03b2-catenin activator inducing lung epithelial organoid formation","volume":"178","author":"Costa","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib342","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00018-015-2076-y","article-title":"WNT-5A: signaling and functions in health and disease","volume":"73","author":"Kumawat","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib343","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20160675","article-title":"Noncanonical WNT-5A signaling impairs endogenous lung repair in COPD","volume":"214","author":"Baarsma","year":"2017","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib344","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159884","article-title":"Noncanonical WNT5A controls the activation of latent TGF-\u03b2 to drive fibroblast activation and tissue fibrosis","volume":"134","author":"Trinh-Minh","year":"2024","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib345","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12931-024-02786-2","article-title":"A WNT mimetic with broad spectrum FZD-specificity decreases fibrosis and improves function in a pulmonary damage model","volume":"25","author":"Patel","year":"2024","journal-title":"Respir Res"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100124_bib346","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.cell.2023.05.022","article-title":"Targeted alveolar regeneration with Frizzled-specific agonists","volume":"186","author":"Nabhan","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib347","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.cellsig.2008.02.013","article-title":"Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways","volume":"20","author":"Torii","year":"2008","journal-title":"Cell Signal"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib348","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MAJ.0b013e31824369c5","article-title":"Sustained Wnt\/\u03b2-catenin signaling rescues high glucose induction of transforming growth factor-\u03b21-mediated renal fibrosis","volume":"344","author":"Ho","year":"2012","journal-title":"Am J Med Sci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib349","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1021\/acsmedchemlett.4c00250","article-title":"Structure-activity relationship of potent, selective, and orally bioavailable molecular glue degraders of CK1\u03b1","volume":"15","author":"Nishiguchi","year":"2024","journal-title":"ACS Med Chem Lett"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib350","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202217532","article-title":"Discovery of potent and exquisitely selective inhibitors of kinase CK1 with tunable isoform selectivity","volume":"62","author":"N\u011bmec","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib351","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-018-0236-z","article-title":"Casein kinase 1\u03b1: biological mechanisms and theranostic potential","volume":"16","author":"Jiang","year":"2018","journal-title":"Cell Commun Signal"},{"issue":"7234","key":"10.1016\/j.pharmr.2026.100124_bib352","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature07613","article-title":"Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival","volume":"458","author":"Bid\u00e8re","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib353","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/cdd.2014.238","article-title":"CXXC5 is a negative-feedback regulator of the Wnt\/\u03b2-catenin pathway involved in osteoblast differentiation","volume":"22","author":"Kim","year":"2015","journal-title":"Cell Death Differ"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib354","doi-asserted-by":"crossref","first-page":"375","DOI":"10.15252\/emmm.201505714","article-title":"Small molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy","volume":"8","author":"Kim","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib355","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2353\/ajpath.2010.090803","article-title":"The divergent roles of secreted frizzled related protein-1 (SFRP1) in lung morphogenesis and emphysema","volume":"177","author":"Foronjy","year":"2010","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib356","article-title":"Down-regulation of the canonical Wnt \u03b2-catenin pathway in the airway epithelium of healthy smokers and smokers with COPD","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100124_bib357","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1128\/MCB.06023-11","article-title":"Wnt antagonist SFRP1 functions as a secreted mediator of senescence","volume":"32","author":"Elzi","year":"2012","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib358","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bone.2009.02.013","article-title":"A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation","volume":"44","author":"Bodine","year":"2009","journal-title":"Bone"},{"issue":"7360","key":"10.1016\/j.pharmr.2026.100124_bib359","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature10337","article-title":"Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling","volume":"476","author":"de Lau","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib360","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1242\/dev.013359","article-title":"R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis","volume":"135","author":"Bell","year":"2008","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib361","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3390\/ijms23063089","article-title":"R-spondin2, a positive canonical WNT signaling regulator, controls the expansion and differentiation of distal lung epithelial stem\/progenitor cells in mice","volume":"23","author":"Raslan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100124_bib362","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1198079","article-title":"Identification and validation of G protein-coupled receptors modulating flow-dependent signaling pathways in vascular endothelial cells","volume":"10","author":"Qiu","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"10356","key":"10.1016\/j.pharmr.2026.100124_bib363","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(22)01273-9","article-title":"Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission","volume":"400","author":"Stolz","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib364","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.chest.2018.09.003","article-title":"The aging lung: is lung health good health for older adults?","volume":"155","author":"Bowdish","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.pharmr.2026.100124_bib365","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102339","article-title":"Early life exposures contributing to accelerated lung function decline in adulthood \u2013 a follow-up study of 11,000 adults from the general population","volume":"66","author":"Kirkeleit","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib366","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.202402-0432PP","article-title":"Early life exposures and the development of chronic obstructive pulmonary disease across the life course","volume":"210","author":"Hopkinson","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib367","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.cell.2025.03.011","article-title":"From geroscience to precision geromedicine: understanding and managing aging","volume":"188","author":"Kroemer","year":"2025","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib368","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1183\/09031936.00186914","article-title":"Hallmarks of the ageing lung","volume":"45","author":"Meiners","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2026.100124_bib369","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s42003-019-0532-1","article-title":"Targeting p16-induced senescence prevents cigarette smoke-induced emphysema by promoting IGF1\/Akt1 signaling in mice","volume":"2","author":"Cottage","year":"2019","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib370","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1096\/fj.201800965R","article-title":"MicroRNA-570 is a novel regulator of cellular senescence and inflammaging","volume":"33","author":"Baker","year":"2019","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib371","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93203","article-title":"mTOR pathway activation drives lung cell senescence and emphysema","volume":"3","author":"Houssaini","year":"2018","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib372","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00752-2020","article-title":"Phospholipase A2 receptor 1 promotes lung cell senescence and emphysema in obstructive lung disease","volume":"58","author":"Beaulieu","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib373","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCRESAHA.111.241299","article-title":"Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease","volume":"109","author":"Noureddine","year":"2011","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib374","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1164\/rccm.201810-1975TR","article-title":"Cellular senescence as a mechanism and target in chronic lung diseases","volume":"200","author":"Barnes","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib375","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.chest.2020.01.027","article-title":"Senotherapy: a new horizon for COPD therapy","volume":"158","author":"Baker","year":"2020","journal-title":"Chest"},{"issue":"7372","key":"10.1016\/j.pharmr.2026.100124_bib376","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders","volume":"479","author":"Baker","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib377","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmr.2026.100124_bib378","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104481","article-title":"Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability","volume":"90","author":"Nambiar","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pharmr.2026.100124_bib379","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib380","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1465-9921-11-131","article-title":"Quercetin prevents progression of disease in elastase\/LPS-exposed mice by negatively regulating MMP expression","volume":"11","author":"Ganesan","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib381","article-title":"Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice","volume":"12","author":"Baker","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib382","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2018-000392","article-title":"Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease","volume":"7","author":"Han","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"Suppl 67","key":"10.1016\/j.pharmr.2026.100124_bib383","article-title":"Targeting lung fibroblast senescence to restore ECM regulation in COPD","volume":"62","author":"Woldhuis","year":"2023","journal-title":"Eur Resp J"},{"issue":"Suppl 68","key":"10.1016\/j.pharmr.2026.100124_bib384","article-title":"Navitoclax inhibits senescence in human alveolar type 2 cells from COPD patients","volume":"64","author":"Guo","year":"2024","journal-title":"Eur Resp J"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib385","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s42255-019-0122-z","article-title":"Cardiac glycosides are broad-spectrum senolytics","volume":"1","author":"Guerrero","year":"2019","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib386","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1038\/s41467-019-12888-x","article-title":"Identification and characterization of Cardiac Glycosides as senolytic compounds","volume":"10","author":"Triana-Mart\u00ednez","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib387","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41591-024-02802-4","article-title":"Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results","volume":"30","author":"Crespo-Garcia","year":"2024","journal-title":"Nat Med"},{"issue":"Suppl 68","key":"10.1016\/j.pharmr.2026.100124_bib388","article-title":"Effect of the novel senolytic drug, BCL-xL PROTAC, on small airway epithelial cells in COPD","volume":"64","author":"Devulder","year":"2024","journal-title":"Eur Resp J"},{"key":"10.1016\/j.pharmr.2026.100124_bib389","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cyto.2018.01.004","article-title":"Fisetin inhibits TNF-\u03b1\/NF-\u03baB-induced IL-8 expression by targeting PKC\u03b4 in human airway epithelial cells","volume":"108","author":"Lee","year":"2018","journal-title":"Cytokine"},{"issue":"Suppl 68","key":"10.1016\/j.pharmr.2026.100124_bib390","article-title":"Effect of the putative senotherapy, Fisetin on small airway epithelial cells in COPD","volume":"64","author":"Devulder","year":"2024","journal-title":"Eur Resp J"},{"key":"10.1016\/j.pharmr.2026.100124_bib391","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655048","article-title":"From cell death to regeneration: rebuilding after injury","volume":"9","author":"Guerin","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib392","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02071-2023","article-title":"Airway-derived emphysema-specific alveolar type II cells exhibit impaired regenerative potential in COPD","volume":"64","author":"Hu","year":"2024","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib393","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1465-9921-7-53","article-title":"Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema","volume":"7","author":"Demedts","year":"2006","journal-title":"Respir Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib394","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41422-020-0314-9","article-title":"Elimination of senescent cells by \u03b2-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice","volume":"30","author":"Cai","year":"2020","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib395","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13133","article-title":"Galactose-modified duocarmycin prodrugs as senolytics","volume":"19","author":"Guerrero","year":"2020","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib396","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/s42255-023-00928-2","article-title":"Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype","volume":"5","author":"Maus","year":"2023","journal-title":"Nat Metab"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib397","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112058","article-title":"Selective ablation of primary and paracrine senescent cells by targeting iron dyshomeostasis","volume":"42","author":"Admasu","year":"2023","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib398","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nm.4021","article-title":"Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice","volume":"22","author":"Cloonan","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib399","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","article-title":"Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging","volume":"169","author":"Baar","year":"2017","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100124_bib400","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1039\/D3NA00547J","article-title":"DNA nanoparticles targeting FOXO4 selectively eliminate cigarette smoke-induced senescent lung fibroblasts","volume":"5","author":"Han","year":"2023","journal-title":"Nanoscale Adv"},{"issue":"7983","key":"10.1016\/j.pharmr.2026.100124_bib401","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","article-title":"Apoptotic stress causes mtDNA release during senescence and drives the SASP","volume":"622","author":"Victorelli","year":"2023","journal-title":"Nature"},{"issue":"Suppl 4","key":"10.1016\/j.pharmr.2026.100124_bib402","first-page":"A235","article-title":"P207 senolytic effects of telaglenastat, a glutaminase inhibitor, on senescent airway epithelial cells","volume":"78","author":"Hassibi","year":"2023","journal-title":"Thorax"},{"issue":"7814","key":"10.1016\/j.pharmr.2026.100124_bib403","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"issue":"709","key":"10.1016\/j.pharmr.2026.100124_bib404","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1951","article-title":"NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates","volume":"15","author":"Yang","year":"2023","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib405","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41467-020-16347-w","article-title":"The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice","volume":"11","author":"Yoshida","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib406","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.201708092","article-title":"Senescence and aging: causes, consequences, and therapeutic avenues","volume":"217","author":"McHugh","year":"2018","journal-title":"J Cell Biol"},{"issue":"6616","key":"10.1016\/j.pharmr.2026.100124_bib407","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1126\/science.abf3326","article-title":"Sentinel p16INK4a+ cells in the basement membrane form a reparative niche in the lung","volume":"378","author":"Reyes","year":"2022","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib408","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib409","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1164\/rccm.202012-4510OC","article-title":"Metformin: experimental and clinical evidence for a potential role in emphysema treatment","volume":"204","author":"Polverino","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib410","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.bcp.2012.09.025","article-title":"Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase","volume":"84","author":"Park","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib411","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41598-022-05276-x","article-title":"Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment","volume":"12","author":"Kahnert","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib412","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamainternmed.2024.7811","article-title":"Glucose-lowering medications and risk of chronic obstructive pulmonary disease exacerbations in patients with type 2 diabetes","volume":"185","author":"Ray","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"46","key":"10.1016\/j.pharmr.2026.100124_bib413","doi-asserted-by":"crossref","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100124_bib414","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.3390\/ijms22136856","article-title":"SIRT3 overexpression ameliorates asbestos-induced pulmonary fibrosis, mt-DNA damage, and lung fibrogenic monocyte recruitment","volume":"22","author":"Cheresh","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib415","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1172\/JCI60132","article-title":"SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice","volume":"122","author":"Yao","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2026.100124_bib416","doi-asserted-by":"crossref","DOI":"10.1038\/srep35871","article-title":"Oxidative stress dependent microRNA-34a activation via PI3K\u03b1 reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells","volume":"6","author":"Baker","year":"2016","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100124_bib417","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.3390\/molecules25204649","article-title":"Mechanisms of aging and the preventive effects of resveratrol on age-related diseases","volume":"25","author":"Pyo","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib418","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s43587-024-00758-1","article-title":"Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial","volume":"4","author":"Norheim","year":"2024","journal-title":"Nat Aging"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib419","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1874467212666181127151059","article-title":"Mitochondria-targeted drugs","volume":"12","author":"Zinovkin","year":"2019","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib420","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12931-017-0560-7","article-title":"Augmenting autophagy for prognosis based intervention of COPD-pathophysiology","volume":"18","author":"Bodas","year":"2017","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib421","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaci.2015.01.046","article-title":"Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease","volume":"136","author":"Wiegman","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib422","doi-asserted-by":"crossref","first-page":"L14","DOI":"10.1152\/ajplung.00400.2018","article-title":"TGF-\u03b2 activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formation","volume":"317","author":"Ng-Blichfeldt","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib423","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.scr.2013.08.007","article-title":"TGF-\u03b2 signaling in stromal cells acts upstream of FGF-10 to regulate epithelial stem cell growth in the adult lung","volume":"11","author":"McQualter","year":"2013","journal-title":"Stem Cell Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib424","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1164\/ajrccm.163.6.9908135","article-title":"Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)","volume":"163","author":"Takizawa","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib425","article-title":"Rho-kinase 1\/2 inhibition prevents transforming growth factor-\u03b2-induced effects on pulmonary remodeling and repair","volume":"11","author":"Wu","year":"2020","journal-title":"Front Pharmacol"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100124_bib426","doi-asserted-by":"crossref","first-page":"14855","DOI":"10.1073\/pnas.222561499","article-title":"Potentiation of serum response factor activity by a family of myocardin-related transcription factors","volume":"99","author":"Wang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2026.100124_bib427","doi-asserted-by":"crossref","DOI":"10.1038\/srep30676","article-title":"Regulation of actin dynamics by WNT-5A: implications for human airway smooth muscle contraction","volume":"6","author":"Koopmans","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib428","doi-asserted-by":"crossref","first-page":"L529","DOI":"10.1152\/ajplung.00387.2015","article-title":"Cooperative signaling by TGF-\u03b21 and WNT-11 drives sm-\u03b1-actin expression in smooth muscle via Rho kinase-actin-MRTF-A signaling","volume":"311","author":"Kumawat","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100124_bib429","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejphar.2008.01.056","article-title":"Rho kinase inhibitors: a novel therapeutical intervention in asthma?","volume":"585","author":"Schaafsma","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100124_bib430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.reth.2022.01.005","article-title":"A novel alveolar epithelial cell sheet fabricated under feeder-free conditions for potential use in pulmonary regenerative therapy","volume":"19","author":"Mitsuboshi","year":"2022","journal-title":"Regen Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib431","doi-asserted-by":"crossref","first-page":"L836","DOI":"10.1152\/ajplung.00385.2010","article-title":"Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides","volume":"301","author":"Schweitzer","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib432","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.3390\/ijms22095018","article-title":"Proteases, mucus, and mucosal immunity in chronic lung disease","volume":"22","author":"McKelvey","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib433","first-page":"361","article-title":"Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema","volume":"12","author":"Abboud","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100124_bib434","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1042\/CS20160487","article-title":"Cellular and molecular mechanisms of asthma and COPD","volume":"131","author":"Barnes","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmr.2026.100124_bib435","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251318841","article-title":"Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency","volume":"19","author":"Turner","year":"2025","journal-title":"Ther Adv Respir Dis"},{"issue":"6A","key":"10.1016\/j.pharmr.2026.100124_bib436","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0002-9343(88)80071-8","article-title":"Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency","volume":"84","author":"Hubbard","year":"1988","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib437","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI110360","article-title":"Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects","volume":"68","author":"Gadek","year":"1981","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib438","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/0929867328666210525161942","article-title":"Augmentation therapy with alpha-1 antitrypsin: present and future of production, formulation, and delivery","volume":"29","author":"Bianchera","year":"2022","journal-title":"Curr Med Chem"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmr.2026.100124_bib439","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1164\/ajrccm.160.5.9901055","article-title":"A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy","volume":"160","author":"Dirksen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib440","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.00159408","article-title":"Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency","volume":"33","author":"Dirksen","year":"2009","journal-title":"Eur Respir J"},{"issue":"9991","key":"10.1016\/j.pharmr.2026.100124_bib441","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib442","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00610-2017","article-title":"European respiratory society statement: diagnosis and treatment of pulmonary disease in \u03b11-antitrypsin deficiency","volume":"50","author":"Miravitlles","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib443","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/14712598.2023.2183771","article-title":"Gene therapy for alpha-1 antitrypsin deficiency: an update","volume":"23","author":"Pires Ferreira","year":"2023","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib444","first-page":"282","article-title":"Recombinant alpha-1 antitrypsin-Fc fusion protein INBRX-101 in adults with alpha-1 antitrypsin deficiency: a phase 1 study","volume":"11","author":"Brantly","year":"2024","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib445","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/10430340050015338","article-title":"Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy","volume":"11","author":"Brigham","year":"2000","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib446","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/15412555.2023.2187210","article-title":"Current perspectives on biological therapy for COPD","volume":"20","author":"Yadav","year":"2023","journal-title":"COPD"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib447","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ajpath.2017.02.008","article-title":"Matrix metalloproteinase-28 is a key contributor to emphysema pathogenesis","volume":"187","author":"Manicone","year":"2017","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib448","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0092-8674(92)90391-O","article-title":"Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema","volume":"71","author":"D\u2019Armiento","year":"1992","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib449","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1164\/rccm.200812-1902OC","article-title":"Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease","volume":"181","author":"Gosselink","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib450","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1440-1843.2012.02197.x","article-title":"Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease","volume":"17","author":"Navratilova","year":"2012","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib451","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00011-004-1319-4","article-title":"Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease","volume":"54","author":"Molet","year":"2005","journal-title":"Inflamm Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib452","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/thx.2006.068353","article-title":"Effect of an MMP-9\/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs","volume":"62","author":"Churg","year":"2007","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib453","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pupt.2011.12.011","article-title":"Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate\/severe COPD: a randomised controlled trial","volume":"25","author":"Dahl","year":"2012","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib454","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12931-021-01838-1","article-title":"Targeted delivery of pentagalloyl glucose inhibits matrix metalloproteinase activity and preserves elastin in emphysematous lungs","volume":"22","author":"Parasaram","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib455","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4093870","article-title":"Plasma cathepsin S and cathepsin S\/cystatin C ratios are potential biomarkers for COPD","volume":"2016","author":"Nakajima","year":"2016","journal-title":"Dis Markers"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib456","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.ajpath.2014.06.017","article-title":"Cathepsin E promotes pulmonary emphysema via mitochondrial fission","volume":"184","author":"Zhang","year":"2014","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib457","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01551-2024","article-title":"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: airleaf, a phase II randomised, double-blind, placebo-controlled, dose-finding study","volume":"65","author":"Chalmers","year":"2025","journal-title":"Eur Respir J"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100124_bib458","doi-asserted-by":"crossref","first-page":"11857","DOI":"10.1021\/acs.jmedchem.1c00104","article-title":"Discovery and in vivo anti-inflammatory activity evaluation of a novel non-peptidyl non-covalent cathepsin C inhibitor","volume":"64","author":"Chen","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100124_bib459","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1231047","article-title":"Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis","volume":"14","author":"McDonald","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib460","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-023-02444-z","article-title":"Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial","volume":"24","author":"Cipolla","year":"2023","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib461","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s000110050440","article-title":"Inhibition of elastase-induced acute inflammation and pulmonary emphysema in hamsters by a novel neutrophil elastase inhibitor FR901277","volume":"48","author":"Fujie","year":"1999","journal-title":"Inflamm Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib462","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082794","article-title":"Inhibition of human neutrophil elastase by pentacyclic triterpenes","volume":"8","author":"Feng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100124_bib463","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pupt.2019.03.009","article-title":"Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: a randomized controlled trial","volume":"56","author":"Watz","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"issue":"26","key":"10.1016\/j.pharmr.2026.100124_bib464","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib465","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1164\/rccm.201211-2055OC","article-title":"Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease","volume":"188","author":"Bracke","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib466","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1164\/rccm.201501-0103OC","article-title":"Role of B cell-activating factor in chronic obstructive pulmonary disease","volume":"192","author":"Seys","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib467","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.200504-594OC","article-title":"Cigarette smoke-induced emphysema: a role for the B cell?","volume":"173","author":"van der Strate","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib468","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1164\/rccm.201501-0107OC","article-title":"B cell-activating factor. An orchestrator of lymphoid follicles in severe chronic obstructive pulmonary disease","volume":"192","author":"Polverino","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib469","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1164\/rccm.201903-0632LE","article-title":"B cell-adaptive immune profile in emphysema-predominant chronic obstructive pulmonary disease","volume":"200","author":"Sullivan","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib470","doi-asserted-by":"crossref","first-page":"L692","DOI":"10.1152\/ajplung.00092.2014","article-title":"Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD","volume":"307","author":"John-Schuster","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib471","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708349","article-title":"Cholesterol metabolism promotes B-cell positioning during immune pathogenesis of chronic obstructive pulmonary disease","volume":"10","author":"Jia","year":"2018","journal-title":"EMBO Mol Med"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib472","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201507-1311OC","article-title":"Network analysis of lung transcriptomics reveals a distinct B-cell signature in emphysema","volume":"193","author":"Faner","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib473","doi-asserted-by":"crossref","first-page":"9562","DOI":"10.1038\/s41598-017-10126-2","article-title":"The cellular and molecular determinants of emphysematous destruction in COPD","volume":"7","author":"Suzuki","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib474","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00839-2024","article-title":"Skewed adaptive immune responses are involved in alpha-1 antitrypsin deficiency emphysema","volume":"65","author":"Rojas-Quintero","year":"2025","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib475","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.183.4.1461","article-title":"Chronic inflammation caused by lymphotoxin is lymphoid neogenesis","volume":"183","author":"Kratz","year":"1996","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib476","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni1330","article-title":"Lymphoid organ development: from ontogeny to neogenesis","volume":"7","author":"Drayton","year":"2006","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib477","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib478","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri1054","article-title":"Organogenesis of lymphoid tissues","volume":"3","author":"Mebius","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib479","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nri2832","article-title":"New insights into the development of lymphoid tissues","volume":"10","author":"van de Pavert","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"5\u20136","key":"10.1016\/j.pharmr.2026.100124_bib480","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1159\/000487057","article-title":"Innate immunity of the lung: from basic mechanisms to translational medicine","volume":"10","author":"Hartl","year":"2018","journal-title":"J Innate Immun"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib481","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.immuni.2004.09.006","article-title":"Induction of secondary and tertiary lymphoid structures in the skin","volume":"21","author":"Cupedo","year":"2004","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib482","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20100052","article-title":"Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells","volume":"208","author":"Lochner","year":"2011","journal-title":"J Exp Med"},{"issue":"36","key":"10.1016\/j.pharmr.2026.100124_bib483","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/onc.2010.260","article-title":"The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development","volume":"29","author":"Wolf","year":"2010","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib484","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/ni.3290","article-title":"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma","volume":"16","author":"Finkin","year":"2015","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib485","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","article-title":"NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100","volume":"7","author":"Xiao","year":"2001","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib486","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(02)00423-5","article-title":"The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways","volume":"17","author":"Dejardin","year":"2002","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib487","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/eji.1830240224","article-title":"A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice","volume":"24","author":"Miyawaki","year":"1994","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib488","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/eji.1830260324","article-title":"The splenic marginal zone is absent in alymphoplastic aly mutant mice","volume":"26","author":"Koike","year":"1996","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib489","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1084\/jem.185.12.2157","article-title":"On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly\/aly) and spleenless (Hox11(-)\/-) mutant mice","volume":"185","author":"Karrer","year":"1997","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib490","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4049\/jimmunol.171.1.115","article-title":"A role for the lymphotoxin\/LIGHT axis in the pathogenesis of murine collagen-induced arthritis","volume":"171","author":"Fava","year":"2003","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib491","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.184.5.1999","article-title":"Surface lymphotoxin alpha\/beta complex is required for the development of peripheral lymphoid organs","volume":"184","author":"Rennert","year":"1996","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib492","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2005.10.002","article-title":"Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function","volume":"23","author":"Browning","year":"2005","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib493","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/cdd.2015.69","article-title":"NIK promotes tissue destruction independently of the alternative NF-\u03baB pathway through TNFR1\/RIP1-induced apoptosis","volume":"22","author":"Boutaffala","year":"2015","journal-title":"Cell Death Differ"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib494","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.str.2012.07.013","article-title":"The crystal structure of the catalytic domain of the NF-\u03baB inducing kinase reveals a narrow but flexible active site","volume":"20","author":"de Leon-Boenig","year":"2012","journal-title":"Structure"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100124_bib495","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.3390\/ijms21145164","article-title":"Small molecule NF-\u03baB pathway inhibitors in clinic","volume":"21","author":"Ramadass","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100124_bib496","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.3390\/molecules29153515","article-title":"Design and synthesis of novel aminoindazole-pyrrolo[2,3-b]pyridine inhibitors of IKK\u03b1 that selectively perturb cellular non-canonical NF-\u03baB signalling","volume":"29","author":"Riley","year":"2024","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib497","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/156801005774912806","article-title":"Inflammatory mediators in chronic obstructive pulmonary disease","volume":"4","author":"Chung","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib498","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.4049\/jimmunol.0803154","article-title":"IL-1R1\/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema","volume":"183","author":"Couillin","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib499","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/01902141003678590","article-title":"Role of interleukin-6 in elastase-induced lung inflammatory changes in mice","volume":"36","author":"Tasaka","year":"2010","journal-title":"Exp Lung Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib500","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1465-9921-14-5","article-title":"IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice","volume":"14","author":"Kurimoto","year":"2013","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib501","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1165\/rcmb.2017-0265OC","article-title":"IL-17 plays a role in respiratory syncytial virus-induced lung inflammation and emphysema in elastase and LPS-injured mice","volume":"58","author":"Mebratu","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib502","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1165\/rcmb.2016-0015OC","article-title":"IL-23 is essential for the development of elastase-induced pulmonary inflammation and emphysema","volume":"55","author":"Fujii","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100124_bib503","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N Engl J Med"},{"issue":"51","key":"10.1016\/j.pharmr.2026.100124_bib504","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.1813927115","article-title":"Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages","volume":"115","author":"Shibata","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib505","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1165\/rcmb.2012-0418OC","article-title":"Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema","volume":"50","author":"Ikeda","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib506","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmr.2026.100124_bib507","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105223","article-title":"Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD","volume":"161","author":"Mei","year":"2020","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib508","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2019.12.002","article-title":"Oral formulation angiotensin-(1-7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase","volume":"225","author":"Bastos","year":"2020","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib509","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tips.2014.11.005","article-title":"Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling","volume":"36","author":"Kistemaker","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib510","doi-asserted-by":"crossref","first-page":"L149","DOI":"10.1152\/ajplung.00268.2023","article-title":"Nicotinic receptors in airway disease","volume":"326","author":"Borkar","year":"2024","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100124_bib511","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.3390\/molecules26206097","article-title":"Nicotinic acetylcholine receptors in the respiratory tract","volume":"26","author":"Hollenhorst","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib512","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10753-023-01953-9","article-title":"Alpha-7 nicotinic receptor agonist protects mice against pulmonary emphysema induced by elastase","volume":"47","author":"Banzato","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmr.2026.100124_bib513","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173239","article-title":"Effects of VAChT reduction and \u03b17nAChR stimulation by PNU-282987 in lung inflammation in a model of chronic allergic airway inflammation","volume":"882","author":"Pinheiro","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib514","first-page":"425","article-title":"Neuropeptide expression in the airways of COPD patients and smokers with normal lung function","volume":"24","author":"Vatrella","year":"2010","journal-title":"J Biol Regul Homeost Agents"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib515","doi-asserted-by":"crossref","first-page":"L539","DOI":"10.1152\/ajplung.00353.2020","article-title":"Protective effects of neuropeptide Y against elastase-induced pulmonary emphysema","volume":"322","author":"Taniguchi","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2026.100124_bib516","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12931-016-0363-2","article-title":"Advanced glycation endproducts and their receptor in different body compartments in COPD","volume":"17","author":"Hoonhorst","year":"2016","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib517","doi-asserted-by":"crossref","first-page":"L641","DOI":"10.1152\/ajplung.00138.2021","article-title":"LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE","volume":"321","author":"Pouwels","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib518","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1096\/fj.201601155R","article-title":"Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling","volume":"31","author":"Lee","year":"2017","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib519","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/stem.2419","article-title":"Mesenchymal stromal cells are readily recoverable from lung tissue, but not the alveolar space, in healthy humans","volume":"34","author":"Sinclair","year":"2016","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib520","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI29713","article-title":"Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts","volume":"117","author":"Lama","year":"2007","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib521","doi-asserted-by":"crossref","first-page":"37","DOI":"10.62347\/JAWM2040","article-title":"Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic","volume":"13","author":"Yuan","year":"2024","journal-title":"Am J Stem Cells"},{"key":"10.1016\/j.pharmr.2026.100124_bib522","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fgene.2018.00418","article-title":"Fgf10 signaling in lung development, homeostasis, disease, and repair after injury","volume":"9","author":"Yuan","year":"2018","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib523","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1242\/dev.099747","article-title":"Fgf10-positive cells represent a progenitor cell population during lung development and postnatally","volume":"141","author":"El Agha","year":"2014","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib524","doi-asserted-by":"crossref","first-page":"L858","DOI":"10.1152\/ajplung.00366.2024","article-title":"Lower levels of senescence in human lung mesenchymal stromal cells compared with lung fibroblasts: implications for tissue regeneration in COPD","volume":"328","author":"Wisman","year":"2025","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib525","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13287-021-02143-w","article-title":"MSC-NTF (NurOwn\u00ae) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model","volume":"12","author":"Kaspi","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib526","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.600711","article-title":"Mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and perspectives","volume":"9","author":"Abreu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib527","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.chest.2023.06.024","article-title":"Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for the treatment of respiratory failure from COVID-19: a randomized, placebo-controlled dosing clinical trial","volume":"164","author":"Lightner","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.pharmr.2026.100124_bib528","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-0716-1225-5_7","article-title":"Study of mesenchymal stem cell-mediated mitochondrial transfer in in vitro models of oxidant-mediated airway epithelial and smooth muscle cell injury","volume":"2269","author":"Michaeloudes","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib529","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaci.2017.08.017","article-title":"Mesenchymal stem cells alleviate oxidative stress-induced mitochondrial dysfunction in the airways","volume":"141","author":"Li","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib530","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1165\/rcmb.2013-0529OC","article-title":"Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage","volume":"51","author":"Li","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib531","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000488149","article-title":"Mesenchymal stromal cells to regenerate emphysema: on the horizon?","volume":"96","author":"Kruk","year":"2018","journal-title":"Respiration"},{"issue":"9624","key":"10.1016\/j.pharmr.2026.100124_bib532","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"issue":"10051","key":"10.1016\/j.pharmr.2026.100124_bib533","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib534","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.humimm.2017.12.008","article-title":"Mesenchymal stromal cells for tolerance induction in organ transplantation","volume":"79","author":"Casiraghi","year":"2018","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib535","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1378\/chest.12-2094","article-title":"A placebo-controlled, randomized trial of mesenchymal stem cells in COPD","volume":"143","author":"Weiss","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib536","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12931-021-01734-8","article-title":"Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels","volume":"22","author":"Weiss","year":"2021","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib537","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/qjmed\/hcw001","article-title":"A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema","volume":"109","author":"Stolk","year":"2016","journal-title":"QJM"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib538","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1089\/scd.2011.0105","article-title":"Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung","volume":"20","author":"Hoffman","year":"2011","journal-title":"Stem Cells Dev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib539","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12931-014-0118-x","article-title":"Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema","volume":"15","author":"Antunes","year":"2014","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib540","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cea.13048","article-title":"Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma","volume":"48","author":"Kitoko","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pharmr.2026.100124_bib541","article-title":"Nebulized mesenchymal stem cell-derived exosomes attenuate airway inflammation in a rat model of chronic obstructive pulmonary disease","author":"Wang","year":"2025","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib542","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13287-015-0093-2","article-title":"Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria","volume":"6","author":"Souza","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib543","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4046\/trd.2014.77.3.116","article-title":"Tracking intravenous adipose-derived mesenchymal stem cells in a model of elastase-induced emphysema","volume":"77","author":"Kim","year":"2014","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib544","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13287-018-0802-8","article-title":"Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases","volume":"9","author":"Silva","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib545","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.94","article-title":"Targeting extracellular vesicle delivery to the lungs by microgel encapsulation","volume":"2","author":"Cober","year":"2023","journal-title":"J Extracell Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib546","doi-asserted-by":"crossref","first-page":"L832","DOI":"10.1152\/ajplung.00147.2020","article-title":"Abnormalities in reparative function of lung-derived mesenchymal stromal cells in emphysema","volume":"320","author":"Kruk","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib547","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaci.2016.06.062","article-title":"Genome-wide association study on the FEV1\/FVC ratio in never-smokers identifies HHIP and FAM13A","volume":"139","author":"van der Plaat","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib548","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1172\/JCI99435","article-title":"Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib549","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2023.01.032","article-title":"Dysregulated lung stroma drives emphysema exacerbation by potentiating resident lymphocytes to suppress an epithelial stem cell reservoir","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib550","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41556-020-00591-9","article-title":"Gli1+ mesenchymal stromal cells form a pathological niche to promote airway progenitor metaplasia in the fibrotic lung","volume":"22","author":"Cassandras","year":"2020","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmr.2026.100124_bib551","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108295","article-title":"Hedgehog pathway and its inhibitors in chronic obstructive pulmonary disease (COPD)","volume":"240","author":"Lahmar","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib552","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41536-019-0080-9","article-title":"Mesenchyme-free expansion and transplantation of adult alveolar progenitor cells: steps toward cell-based regenerative therapies","volume":"4","author":"Weiner","year":"2019","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib553","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1201658","article-title":"Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD","volume":"14","author":"Raby","year":"2023","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib554","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1164\/rccm.201704-0667OC","article-title":"Exhaustion of airway basal progenitor cells in early and established chronic obstructive pulmonary disease","volume":"197","author":"Ghosh","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3\u20134","key":"10.1016\/j.pharmr.2026.100124_bib555","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/ten.tea.2023.0214","article-title":"Comparative study of immunodeficient rat strains in engraftment of human-induced pluripotent stem cell-derived airway epithelia","volume":"30","author":"Hayashi","year":"2024","journal-title":"Tissue Eng Part A"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib556","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.stem.2023.07.014","article-title":"Airway stem cell reconstitution by the transplantation of primary or pluripotent stem cell-derived basal cells","volume":"30","author":"Ma","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib557","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41596-024-01067-y","article-title":"Life-long functional regeneration of in vivo airway epithelium by the engraftment of airway basal stem cells","volume":"20","author":"Ma","year":"2025","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib558","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stemcr.2017.11.012","article-title":"In vitro induction and in vivo engraftment of lung bud tip progenitor cells derived from human pluripotent stem cells","volume":"10","author":"Miller","year":"2018","journal-title":"Stem Cell Rep"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib559","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.stem.2023.07.016","article-title":"Durable alveolar engraftment of PSC-derived lung epithelial cells into immunocompetent mice","volume":"30","author":"Herriges","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib560","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2017.08.014","article-title":"Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells","volume":"21","author":"Jacob","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib561","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s13238-018-0506-y","article-title":"Regeneration of functional alveoli by adult human SOX9+ airway basal cell transplantation","volume":"9","author":"Ma","year":"2018","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib562","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13287-019-1257-2","article-title":"Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice","volume":"10","author":"Shi","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib563","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13046","article-title":"Intrapulmonary distal airway stem cell transplantation repairs lung injury in chronic obstructive pulmonary disease","volume":"54","author":"Wang","year":"2021","journal-title":"Cell Prolif"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib564","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110662","article-title":"Progenitor potential of lung epithelial organoid cells in a transplantation model","volume":"39","author":"Louie","year":"2022","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib565","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1165\/rcmb.2021-0263LE","article-title":"Comparison of transplantation of lung organoid cell types: one size does not fit all","volume":"66","author":"Ararat","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"34","key":"10.1016\/j.pharmr.2026.100124_bib566","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk2524","article-title":"Lung cell transplantation for pulmonary fibrosis","volume":"10","author":"Milman Krentsis","year":"2024","journal-title":"Sci Adv"},{"issue":"734","key":"10.1016\/j.pharmr.2026.100124_bib567","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi3360","article-title":"Autologous transplantation of P63+ lung progenitor cells for chronic obstructive pulmonary disease therapy","volume":"16","author":"Wang","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib568","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.102451.3","article-title":"Autologous P63+ lung progenitor cell transplantation in idiopathic pulmonary fibrosis: a phase 1 clinical trial","volume":"13","author":"Zhang","year":"2025","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib569","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa1712770","article-title":"Injection of cultured cells with a ROCK inhibitor for bullous keratopathy","volume":"378","author":"Kinoshita","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib570","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96494-6","article-title":"Tissue engineered corneal endothelium transplantation in an ex vivo human cornea organ culture model","volume":"15","author":"Tsai","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib571","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13787-1","article-title":"Therapy of corneal endothelial dysfunction with corneal endothelial cell-like cells derived from skin-derived precursors","volume":"7","author":"Shen","year":"2017","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100124_bib572","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jacc.2006.12.037","article-title":"Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial","volume":"49","author":"Wang","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib573","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/CIRCRESAHA.114.305951","article-title":"Endothelial NO-synthase gene-enhanced progenitor cell therapy for pulmonary arterial hypertension: the PHACeT trial","volume":"117","author":"Granton","year":"2015","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib574","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1183\/23120541.00983-2020","article-title":"Endothelial dysfunction in COPD: a systematic review and meta-analysis of studies using different functional assessment methods","volume":"7","author":"Theodorakopoulou","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib575","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2147\/COPD.S512275","article-title":"Exercise prescription training in chronic obstructive pulmonary disease: benefits and mechanisms","volume":"20","author":"Liu","year":"2025","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2026.100124_bib576","article-title":"Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib577","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/labinvest.3780385","article-title":"Generation of human pulmonary microvascular endothelial cell lines","volume":"81","author":"Krump-Konvalinkova","year":"2001","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib578","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00745-2017","article-title":"Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: highlights from basic research to therapy","volume":"51","author":"Huertas","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib579","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jtcvs.2023.03.009","article-title":"Intratracheally injected human-induced pluripotent stem cell-derived pneumocytes and endothelial cells engraft in the distal lung and ameliorate emphysema in a rat model","volume":"166","author":"Altalhi","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib580","doi-asserted-by":"crossref","first-page":"L114","DOI":"10.1152\/ajplung.00274.2023","article-title":"Transplantation of alveolar macrophages improves the efficacy of endothelial progenitor cell therapy in mouse model of bronchopulmonary dysplasia","volume":"327","author":"Mohammed","year":"2024","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib581","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/s12967-023-04735-x","article-title":"Endothelial progenitor cells systemic administration alleviates multi-organ senescence by down-regulating USP7\/p300 pathway in chronic obstructive pulmonary disease","volume":"21","author":"Wang","year":"2023","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib582","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0974-2077.150734","article-title":"Principles and methods of preparation of platelet-rich plasma: a review and author\u2019s perspective","volume":"7","author":"Dhurat","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib583","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.3390\/jcm14082714","article-title":"Re-evaluating platelet-rich plasma dosing strategies in sports medicine: the role of the \u201c10 billion platelet dose\u201d in optimizing therapeutic outcomes-a narrative review","volume":"14","author":"Corsini","year":"2025","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib584","first-page":"3096","article-title":"Platelet-rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors","volume":"15","author":"Huang","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib585","article-title":"The effect of intravenous autologous activated platelet-rich plasma therapy on \u201cprofibrotic cytokine\u201d IL-1 \u03b2 levels in severe and critical COVID-19 patients: a preliminary study","volume":"2021","author":"Karina","year":"2021","journal-title":"Scientifica (Cairo)"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib586","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3390\/ijms22041856","article-title":"Platelet lysate nebulization protocol for the treatment of COVID-19 and its sequels: proof of concept and scientific rationale","volume":"22","author":"Beitia","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib587","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1165\/rcmb.2015-0045OC","article-title":"Acceleration of lung regeneration by platelet-rich plasma extract through the low-density lipoprotein receptor-related protein 5-Tie2 pathway","volume":"54","author":"Mammoto","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib588","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ncb3096","article-title":"Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration","volume":"17","author":"Rafii","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib589","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.athoracsur.2020.05.047","article-title":"Bronchoscopic treatment of tracheobronchial fistula with autologous platelet-rich plasma","volume":"111","author":"Wu","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib590","first-page":"1","article-title":"Platelet rich plasma- platelet concentrate therapy in COPD: an observational cohort study","volume":"2","author":"Rubio","year":"2021","journal-title":"J Regen Med Biol Res"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100124_bib591","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713043","article-title":"Advances in platelet rich plasma-derived extracellular vesicles for regenerative medicine: a systematic-narrative review","volume":"24","author":"Anitua","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100124_bib592","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111106","article-title":"Platelet-rich plasma-derived extracellular vesicles inhibit NF-\u03baB\/NLRP3 pathway-mediated pyroptosis in intervertebral disc degeneration via the MALAT1\/microRNA-217\/SIRT1 axis","volume":"117","author":"Tao","year":"2024","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib593","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13287-022-02938-5","article-title":"Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools","volume":"13","author":"Abbaszadeh","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib594","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2019.07.022","article-title":"Mesenchymal stem\/stromal cell secretome for lung regeneration: the long way through \u201cpharmaceuticalization\u201d for the best formulation","volume":"309","author":"Bari","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmr.2026.100124_bib595","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.2147\/COPD.S146671","article-title":"Mesenchymal stromal cell therapy in COPD: from bench to bedside","volume":"12","author":"Antunes","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib596","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/ijms18030538","article-title":"Exosomes: from garbage bins to promising therapeutic targets","volume":"18","author":"Rashed","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib597","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","article-title":"Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine","volume":"9","author":"Keshtkar","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib598","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.04.013","article-title":"Extracellular vesicles for tissue repair and regeneration: evidence, challenges and opportunities","volume":"175","author":"Nagelkerke","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib599","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100124_bib600","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300319","article-title":"A comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles","volume":"12","author":"Gandek","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib601","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13287-020-02088-6","article-title":"Human umbilical cord mesenchymal stem cell-derived extracellular vesicles ameliorate airway inflammation in a rat model of chronic obstructive pulmonary disease (COPD)","volume":"12","author":"Ridzuan","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib602","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.661385","article-title":"Mesenchymal stromal cells from emphysematous donors and their extracellular vesicles are unable to reverse cardiorespiratory dysfunction in experimental severe emphysema","volume":"9","author":"Antunes","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib603","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13287-024-04066-8","article-title":"Intravenous injection of BMSCs modulate tsRNA expression and ameliorate lung remodeling in COPD mice","volume":"15","author":"Jin","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib604","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.127","article-title":"Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway","volume":"49","author":"Kim","year":"2017","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib605","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.trsl.2024.02.001","article-title":"Nebulized platelet-derived extracellular vesicles attenuate chronic cigarette smoke-induced murine emphysema","volume":"269","author":"Xuan","year":"2024","journal-title":"Transl Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib606","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122604","article-title":"Isolation of extracellular vesicles with combined enrichment methods","volume":"1169","author":"Stam","year":"2021","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pharmr.2026.100124_bib607","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3402\/jev.v2i0.19861","article-title":"How pure are your vesicles?","volume":"2","author":"Webber","year":"2013","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib608","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1807674","article-title":"Experimental artefacts can lead to misattribution of bioactivity from soluble mesenchymal stem cell paracrine factors to extracellular vesicles","volume":"9","author":"Whittaker","year":"2020","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib609","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13287-023-03385-6","article-title":"Nebulised mesenchymal stem cell derived extracellular vesicles ameliorate E. coli induced pneumonia in a rodent model","volume":"14","author":"Gonzalez","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100124_bib610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib611","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijpharm.2018.07.008","article-title":"Challenges for pulmonary delivery of high powder doses","volume":"548","author":"Sibum","year":"2018","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib612","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/pharmaceutics12010055","article-title":"Influence of composition and spray-drying process parameters on carrier-free DPI properties and behaviors in the lung: a review","volume":"12","author":"Lechanteur","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib613","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib614","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121115","article-title":"Innovative drying technologies for biopharmaceuticals","volume":"609","author":"Sharma","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharmr.2026.100124_bib615","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2019.06.027","article-title":"Achieving continuous manufacturing in lyophilization: technologies and approaches","volume":"142","author":"Pisano","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharmr.2026.100124_bib616","article-title":"Stabilized extracellular vesicle formulations for inhalable dry powder development","author":"Jansen","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.pharmr.2026.100124_bib617","doi-asserted-by":"crossref","first-page":"0005","DOI":"10.34133\/bmr.0005","article-title":"Lyoprotectant constituents suited for lyophilization and reconstitution of stem-cell-derived extracellular vesicles","volume":"28","author":"Kang","year":"2024","journal-title":"Biomater Res"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100124_bib618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.10.032","article-title":"Preservation of exosomes at room temperature using lyophilization","volume":"553","author":"Charoenviriyakul","year":"2018","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib619","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30786-y","article-title":"Extracellular vesicles protect glucuronidase model enzymes during freeze-drying","volume":"8","author":"Frank","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib620","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.matt.2022.06.012","article-title":"Inhalable dry powder mRNA vaccines based on extracellular vesicles","volume":"5","author":"Popowski","year":"2022","journal-title":"Matter"},{"key":"10.1016\/j.pharmr.2026.100124_bib621","article-title":"Molecular and cellular mechanisms responsible for beneficial effects of mesenchymal stem cell-derived product \u201cExo-d-MAPPS\u201d in attenuation of chronic airway inflammation","volume":"2020","author":"Harrell","year":"2020","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100124_bib622","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810522","article-title":"Methods of the large-scale production of extracellular vesicles","volume":"23","author":"Syromiatnikova","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib623","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.115","article-title":"Cell culture-derived extracellular vesicles: considerations for reporting cell culturing parameters","volume":"2","author":"Shekari","year":"2023","journal-title":"J Extracell Biol"},{"key":"10.1016\/j.pharmr.2026.100124_bib624","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113843","article-title":"Technological advances towards extracellular vesicles mass production","volume":"176","author":"Grangier","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib625","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99263","article-title":"Generation and testing of clinical-grade exosomes for pancreatic cancer","volume":"3","author":"Mendt","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib626","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1442088","article-title":"Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15\/lactadherin complexes","volume":"7","author":"Watson","year":"2018","journal-title":"J Extracell Vesicles"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100124_bib627","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.3390\/ijms23147986","article-title":"Scalable production of extracellular vesicles and its therapeutic values: a review","volume":"23","author":"Ng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100124_bib628","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2018.02.002","article-title":"Subpopulations of extracellular vesicles and their therapeutic potential","volume":"60","author":"L\u00e4sser","year":"2018","journal-title":"Mol Aspects Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib629","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrm3528","article-title":"Exploring mechanisms of FGF signalling through the lens of structural biology","volume":"14","author":"Goetz","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib630","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"issue":"88","key":"10.1016\/j.pharmr.2026.100124_bib631","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000304","article-title":"Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis","volume":"2","author":"Makarenkova","year":"2009","journal-title":"Sci Signal"},{"issue":"28","key":"10.1016\/j.pharmr.2026.100124_bib632","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib633","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/path.1748","article-title":"Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1","volume":"206","author":"Kranenburg","year":"2005","journal-title":"J Pathol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib634","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw3851","article-title":"Single-cell connectomic analysis of adult mammalian lungs","volume":"5","author":"Raredon","year":"2019","journal-title":"Sci Adv"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib635","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/thoraxjnl-2011-200017","article-title":"Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease","volume":"66","author":"Brehm","year":"2011","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib636","doi-asserted-by":"crossref","first-page":"L350","DOI":"10.1152\/ajplung.00161.2002","article-title":"FGF-10 prevents mechanical stretch-induced alveolar epithelial cell DNA damage via MAPK activation","volume":"284","author":"Upadhyay","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib637","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<424::AID-JCP6>3.0.CO;2-Z","article-title":"Keratinocyte growth factor accelerates wound closure in airway epithelium during cyclic mechanical strain","volume":"181","author":"Waters","year":"1999","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmr.2026.100124_bib638","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.isci.2018.12.022","article-title":"Mesenchymal-epithelial interactome analysis reveals essential factors required for fibroblast-free alveolosphere formation","volume":"11","author":"Shiraishi","year":"2019","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib639","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1172\/JCI58097","article-title":"Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury","volume":"121","author":"Volckaert","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib640","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ydbio.2007.04.033","article-title":"Fgf10 dosage is critical for the amplification of epithelial cell progenitors and for the formation of multiple mesenchymal lineages during lung development","volume":"307","author":"Ramasamy","year":"2007","journal-title":"Dev Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib641","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<398::AID-AJA10>3.0.CO;2-X","article-title":"FGF-1 and FGF-7 induce distinct patterns of growth and differentiation in embryonic lung epithelium","volume":"208","author":"Cardoso","year":"1997","journal-title":"Dev Dyn"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib642","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1165\/ajrcmb.18.2.2824","article-title":"KGF increases SP-A and SP-D mRNA levels and secretion in cultured rat alveolar type II cells","volume":"18","author":"Xu","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib643","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1165\/ajrcmb.20.3.3201","article-title":"Keratinocyte growth factor enhances maturation of fetal rat lung type II cells","volume":"20","author":"Chelly","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib644","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1073\/pnas.1031851100","article-title":"Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia","volume":"100","author":"Ray","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib645","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.200904-0544OC","article-title":"Fibroblast growth factor receptors control epithelial-mesenchymal interactions necessary for alveolar elastogenesis","volume":"181","author":"Srisuma","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib646","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1165\/rcmb.2014-0184OC","article-title":"Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin","volume":"52","author":"Guzy","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib647","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s10020-020-00221-y","article-title":"Fibroblast growth factor-2 alleviates the capillary leakage and inflammation in sepsis","volume":"26","author":"Pan","year":"2020","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib648","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/15412555.2023.2174842","article-title":"PTD-FGF2 attenuates elastase induced emphysema in mice and alveolar epithelial cell injury","volume":"20","author":"Jang","year":"2023","journal-title":"COPD"},{"key":"10.1016\/j.pharmr.2026.100124_bib649","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114147","article-title":"The early and late intervention effects of collagen-binding FGF2 on elastase-induced lung injury","volume":"158","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib650","doi-asserted-by":"crossref","first-page":"L988","DOI":"10.1152\/ajplung.2000.278.5.L988","article-title":"KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT","volume":"278","author":"Panoskaltsis-Mortari","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib651","doi-asserted-by":"crossref","first-page":"L163","DOI":"10.1152\/ajplung.00396.2001","article-title":"Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms","volume":"283","author":"Atabai","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib652","doi-asserted-by":"crossref","first-page":"L1179","DOI":"10.1152\/ajplung.00450.2004","article-title":"Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury","volume":"288","author":"Ulrich","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib653","article-title":"Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib654","doi-asserted-by":"crossref","first-page":"L1230","DOI":"10.1152\/ajplung.00460.2006","article-title":"Keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice","volume":"293","author":"Plantier","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100124_bib655","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/08958378.2014.957426","article-title":"Effect of recombinant human keratinocyte growth factor in inducing Ras-Raf-Erk pathway-mediated cell proliferation in emphysematous mice lung","volume":"26","author":"Muyal","year":"2014","journal-title":"Inhal Toxicol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib656","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1164\/rccm.201310-1892OC","article-title":"Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury","volume":"189","author":"Shyamsundar","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib657","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112165","article-title":"FGF10 protects against particulate matter-induced lung injury by inhibiting ferroptosis via Nrf2-dependent signaling","volume":"134","author":"Qian","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"Pt A","key":"10.1016\/j.pharmr.2026.100124_bib658","article-title":"Fibroblast growth factor 10 protects against particulate matter-induced lung injury by inhibiting oxidative stress-mediated pyroptosis via the PI3K\/Akt\/Nrf2 signaling pathway","volume":"113","author":"Liu","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib659","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01606-2022","article-title":"Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice","volume":"62","author":"Hadzic","year":"2023","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib660","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12931-022-02193-5","article-title":"Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis","volume":"23","author":"Jiang","year":"2022","journal-title":"Respir Res"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib661","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/cancers10090280","article-title":"Status of agents targeting the HGF\/c-Met axis in lung cancer","volume":"10","author":"Miranda","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"28","key":"10.1016\/j.pharmr.2026.100124_bib662","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1972","article-title":"Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis","volume":"6","author":"Habermann","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.pharmr.2026.100124_bib663","first-page":"35","article-title":"Development of antibody-based c-Met inhibitors for targeted cancer therapy","volume":"4","author":"Lee","year":"2015","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib664","article-title":"Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study","volume":"10","author":"Jung","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib665","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1378\/chest.14-0373","article-title":"Simultaneous assessment of hepatocyte growth factor and vascular endothelial growth factor in epithelial lining fluid from patients with COPD","volume":"146","author":"Kanazawa","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib666","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/COPD.S3078","article-title":"Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease","volume":"3","author":"Sauleda","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2026.100124_bib667","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678661","article-title":"Chronic obstructive pulmonary disease patients have increased levels of plasma inflammatory mediators reported upregulated in severe COVID-19","volume":"12","author":"Acevedo","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib668","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003228","article-title":"Hepatocyte growth factor, a determinant of airspace homeostasis in the murine lung","volume":"9","author":"Calvi","year":"2013","journal-title":"PLoS Genet"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib669","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000158433.89103.85","article-title":"Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats","volume":"111","author":"Shigemura","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib670","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/mt.2008.137","article-title":"Intranasal HGF administration ameliorates the physiologic and morphologic changes in lung emphysema","volume":"16","author":"Hegab","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib671","doi-asserted-by":"crossref","DOI":"10.1038\/srep38207","article-title":"Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD","volume":"6","author":"Kennelly","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100124_bib672","doi-asserted-by":"crossref","DOI":"10.1038\/srep41901","article-title":"Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells","volume":"7","author":"Nita","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib673","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/bbrc.1997.7526","article-title":"Involvement of hepatocyte growth factor in formation of bronchoalveolar structures in embryonic rat lung in primary culture","volume":"241","author":"Itakura","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib674","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/cimb47030156","article-title":"A comprehensive review exploring the role of bone morphogenetic proteins [BMP]: biological mechanisms","volume":"47","author":"Kalal","year":"2025","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib675","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1535370219828694","article-title":"Bone morphogenetic protein signaling in inflammation","volume":"244","author":"Wu","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib676","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/cells9020280","article-title":"The role of bone morphogenetic protein 7 (BMP-7) in inflammation in heart diseases","volume":"9","author":"Aluganti Narasimhulu","year":"2020","journal-title":"Cells"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100124_bib677","doi-asserted-by":"crossref","DOI":"10.1242\/dev.204253","article-title":"Correction: niche-mediated BMP\/SMAD signaling regulates lung alveolar stem cell proliferation and differentiation","volume":"151","author":"Chung","year":"2024","journal-title":"Development"},{"key":"10.1016\/j.pharmr.2026.100124_bib678","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbrc.2023.03.020","article-title":"Intrinsic BMP inhibitor Gremlin regulates alveolar epithelial type II cell proliferation and differentiation","volume":"656","author":"Yanagihara","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib679","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/stem.3125","article-title":"The noncanonical BMP signaling pathway plays an important role in club cell regeneration","volume":"38","author":"Shafiquzzaman","year":"2020","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib680","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/path.6234","article-title":"Downregulated BMP-Smad1\/5\/8 signaling causes emphysema via dysfunction of alveolar type II epithelial cells","volume":"262","author":"Zheng","year":"2024","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib681","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41385-018-0116-2","article-title":"Bone morphogenetic protein 6 (BMP-6) modulates lung function, pulmonary iron levels and cigarette smoke-induced inflammation","volume":"12","author":"Verhamme","year":"2019","journal-title":"Mucosal Immunol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib682","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ng.3011","article-title":"Genome-wide association analysis identifies six new loci associated with forced vital capacity","volume":"46","author":"Loth","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmr.2026.100124_bib683","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2147\/COPD.S364982","article-title":"Sputum cytokine profiling in COPD: comparison between stable disease and exacerbation","volume":"17","author":"Barta","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2026.100124_bib684","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2147\/JIR.S458580","article-title":"Transcriptomic insights into different stimulation intensity of electroacupuncture in treating COPD in rat models","volume":"17","author":"Liu","year":"2024","journal-title":"J Inflamm Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib685","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib686","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1096\/fj.201700193RR","article-title":"Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence","volume":"31","author":"Benn","year":"2017","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib687","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1541-7786.141.2.3","article-title":"Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors","volume":"2","author":"Langenfeld","year":"2004","journal-title":"Mol Cancer Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib688","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) \u2013 key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom J Morphol Embryol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib689","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3390\/cells11101720","article-title":"Angiogenesis, lymphangiogenesis, and inflammation in chronic obstructive pulmonary disease (COPD): few certainties and many outstanding questions","volume":"11","author":"Poto","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib690","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BSR20110077","article-title":"Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides","volume":"32","author":"Zhao","year":"2012","journal-title":"Biosci Rep"},{"key":"10.1016\/j.pharmr.2026.100124_bib691","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vph.2016.05.011","article-title":"VEGF receptor signal transduction \u2013 a brief update","volume":"86","author":"Claesson-Welsh","year":"2016","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib692","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1183\/09031936.03.00030403","article-title":"Imbalance between vascular endothelial growth factor and endostatin in emphysema","volume":"22","author":"Kanazawa","year":"2003","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib693","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.coph.2008.03.003","article-title":"Vascular endothelial growth factor of the lung: friend or foe","volume":"8","author":"Tuder","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100124_bib694","article-title":"The role of vascular endothelial growth factor in small-airway remodelling in a rat model of chronic obstructive pulmonary disease","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100124_bib695","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251332469","article-title":"Quantitative chest computed tomography in chronic obstructive pulmonary disease: assessing the role of emphysema severity and its correlation with clinical characteristics, lung function, and plasma levels of VEGF and IL-1\u03b2","volume":"19","author":"Nguyen Hai","year":"2025","journal-title":"Ther Adv Respir Dis"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib696","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/medicina57121351","article-title":"Increased vascular endothelial growth factor serum level and the role of +936C\/T gene polymorphism in chronic obstructive pulmonary disease","volume":"57","author":"Chis","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib697","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/thx.2006.064428","article-title":"Profiling serum biomarkers in patients with COPD: associations with clinical parameters","volume":"62","author":"Pinto-Plata","year":"2007","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib698","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI10259","article-title":"Inhibition of VEGF receptors causes lung cell apoptosis and emphysema","volume":"106","author":"Kasahara","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2026.100124_bib699","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1168676","article-title":"PR1P, a VEGF-stabilizing peptide, reduces injury and inflammation in acute lung injury and ulcerative colitis animal models","volume":"14","author":"Adini","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib700","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1165\/rcmb.2019-0434OC","article-title":"PR1P stabilizes VEGF and upregulates its signaling to reduce elastase-induced murine emphysema","volume":"63","author":"Adini","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib701","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1096\/fj.201500096R","article-title":"The diverse functions of osteoglycin: a deceitful dwarf, or a master regulator of disease?","volume":"30","author":"Deckx","year":"2016","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib702","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/biom12111674","article-title":"Osteoglycin: an ECM factor regulating fibrosis and tumorigenesis","volume":"12","author":"Nulali","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib703","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41536-025-00404-3","article-title":"Fibroblast-derived osteoglycin promotes epithelial cell repair","volume":"10","author":"van der Koog","year":"2025","journal-title":"NPJ Regen Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib704","doi-asserted-by":"crossref","first-page":"L799","DOI":"10.1152\/ajplung.00334.2022","article-title":"Age-associated differences in the human lung extracellular matrix","volume":"324","author":"Koloko Ngassie","year":"2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2026.100124_bib705","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2147\/COPD.S216050","article-title":"Roundabout signaling pathway involved in the pathogenesis of COPD by integrative bioinformatics analysis","volume":"14","author":"Lin","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib706","doi-asserted-by":"crossref","first-page":"C895","DOI":"10.1152\/ajpcell.00479.2019","article-title":"Overexpressed microRNA-140 inhibits pulmonary fibrosis in interstitial lung disease via the Wnt signaling pathway by downregulating osteoglycin","volume":"319","author":"Shi","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib707","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cvr\/cvy035","article-title":"Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3\/matrix metalloproteinase 2\/epidermal growth factor receptor signalling","volume":"114","author":"Zuo","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2026.100124_bib708","doi-asserted-by":"crossref","first-page":"10639","DOI":"10.2147\/OTT.S222967","article-title":"Osteoglycin (OGN) inhibits cell proliferation and invasiveness in breast cancer via PI3K\/Akt\/mTOR signaling pathway","volume":"12","author":"Xu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.pharmr.2026.100124_bib709","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molmet.2018.05.004","article-title":"Osteoglycin, a novel coordinator of bone and glucose homeostasis","volume":"13","author":"Lee","year":"2018","journal-title":"Mol Metab"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100124_bib710","doi-asserted-by":"crossref","first-page":"558","DOI":"10.14348\/molcells.2023.0097","article-title":"Recombinant human HAPLN1 mitigates pulmonary emphysema by increasing TGF-\u03b2 receptor I and sirtuins levels in human alveolar epithelial cells","volume":"46","author":"Piao","year":"2023","journal-title":"Mol Cells"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib711","doi-asserted-by":"crossref","first-page":"L268","DOI":"10.1152\/ajplung.00151.2016","article-title":"A keratan sulfate disaccharide prevents inflammation and the progression of emphysema in murine models","volume":"312","author":"Gao","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2026.100124_bib712","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.2147\/COPD.S531972","article-title":"Lung cancer risk in US adults with COPD: a systematic review and meta-analysis","volume":"20","author":"Obeng-Nyarkoh","year":"2025","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2026.100124_bib713","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105769","article-title":"Global regulatory considerations and practices for tumorigenicity evaluation of cell-based therapy","volume":"156","author":"Dou","year":"2025","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib714","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13287-024-03940-9","article-title":"Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option","volume":"15","author":"Lai","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib715","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib717","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.201310-1863PP","article-title":"Minimal clinically important differences in pharmacological trials","volume":"189","author":"Jones","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib718","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1081\/COPD-200053377","article-title":"Minimal clinically important differences in COPD lung function","volume":"2","author":"Donohue","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.pharmr.2026.100124_bib719","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3389\/fphar.2019.01519","article-title":"Healthcare professionals\u2019 preferred efficacy endpoints and minimal clinically important differences in the assessment of new medicines for chronic obstructive pulmonary disease","volume":"10","author":"Dankers","year":"2019","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib720","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/15412550701471231","article-title":"How can we assess outcomes of clinical trials: the MCID approach","volume":"4","author":"Make","year":"2007","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib721","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib722","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1164\/rccm.202303-0400SO","article-title":"An update on outcomes for COPD pharmacological trials: a COPD investigators report \u2013 reassessment of the 2008 American Thoracic Society\/European Respiratory Society statement on outcomes for COPD pharmacological trials","volume":"208","author":"Cazzola","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100124_bib723","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100124_bib724","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib725","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.201509-1722PP","article-title":"Plasma fibrinogen qualification as a drug development tool in chronic obstructive pulmonary disease. perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium","volume":"193","author":"Miller","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib726","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1378\/chest.07-1342","article-title":"Increased systemic inflammation is a risk factor for COPD exacerbations","volume":"133","author":"Groenewegen","year":"2008","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib727","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100124_bib728","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Danesh","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib729","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/15412555.2012.668249","article-title":"Fibrinogen, COPD and mortality in a nationally representative U.S. cohort","volume":"9","author":"Mannino","year":"2012","journal-title":"COPD"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib730","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/15412555.2021.2009791","article-title":"Predicting mortality in COPD with validated and sensitive biomarkers; fibrinogen and mid-range-proadrenomedullin (MR-proADM)","volume":"18","author":"Zuur-Telgen","year":"2021","journal-title":"COPD"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100124_bib731","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jpha.2023.08.014","article-title":"Recent advancements in single-cell metabolic analysis for pharmacological research","volume":"13","author":"Hou","year":"2023","journal-title":"J Pharm Anal"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib732","first-page":"395","article-title":"Advances in mass spectrometry-based single cell analysis","volume":"12","author":"Lee","year":"2023","journal-title":"Biology (Basel)"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib733","article-title":"Applications of multi-omics analysis in human diseases","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm (2020)"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib734","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41573-023-00688-4","article-title":"Applications of single-cell RNA sequencing in drug discovery and development","volume":"22","author":"Van de Sande","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib735","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1164\/rccm.201501-0137PP","article-title":"Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung","volume":"192","author":"Yonchuk","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib736","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/cs0960033","article-title":"Increased plasma levels of adrenomedullin in patients with pulmonary hypertension","volume":"96","author":"Kakishita","year":"1999","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib737","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.08-0047","article-title":"Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD","volume":"134","author":"Stolz","year":"2008","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib738","first-page":"18","article-title":"The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease","volume":"2015","author":"Zien Alaabden","year":"2015","journal-title":"Qatar Med J"},{"key":"10.1016\/j.pharmr.2026.100124_bib739","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-7-13","article-title":"Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study","volume":"7","author":"Sin","year":"2007","journal-title":"BMC Pulm Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib740","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/15412555.2012.736317","article-title":"Surfactant protein D as a biomarker for chronic obstructive pulmonary disease","volume":"9","author":"Bowler","year":"2012","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib741","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1872214808666140209142640","article-title":"Surfactant protein D in chornic obstructive pulmonary disease (COPD)","volume":"8","author":"Moreno","year":"2014","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib742","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/jpm12030379","article-title":"Incorporating biomarkers in COPD management: the research keeps going","volume":"12","author":"Pantazopoulos","year":"2022","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100124_bib743","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MCP.0000000000000549","article-title":"Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise","volume":"25","author":"Mannino","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib744","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12931-017-0597-7","article-title":"Multiple biomarkers predict disease severity, progression and mortality in COPD","volume":"18","author":"Zemans","year":"2017","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib745","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000431","article-title":"Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial","volume":"6","author":"Celli","year":"2019","journal-title":"BMJ Open Respir Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100124_bib746","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/diagnostics10121029","article-title":"Combination of systemic inflammatory biomarkers in assessment of chronic obstructive pulmonary disease: diagnostic performance and identification of networks and clusters","volume":"10","author":"Hlap\u010di\u0107","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib747","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1183\/23120541.00301-2022","article-title":"Biomarker-based clustering of patients with chronic obstructive pulmonary disease","volume":"9","author":"Vanfleteren","year":"2023","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib748","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/bmb\/ldaa043","article-title":"The different phenotypes of COPD","volume":"137","author":"Yousuf","year":"2021","journal-title":"Br Med Bull"},{"issue":"169","key":"10.1016\/j.pharmr.2026.100124_bib749","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0223-2022","article-title":"Regenerative and translational medicine in COPD: hype and hope","volume":"32","author":"Guarnier","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib750","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12931-023-02349-x","article-title":"Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD","volume":"24","author":"Zhang","year":"2023","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib751","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12931-017-0631-9","article-title":"Using omics approaches to understand pulmonary diseases","volume":"18","author":"Kan","year":"2017","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib752","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","article-title":"An integrated cell atlas of the lung in health and disease","volume":"29","author":"Sikkema","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmr.2026.100124_bib753","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/COPD.S330817","article-title":"Treatable traits in COPD \u2013 a proposed approach","volume":"16","author":"Cardoso","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2026.100124_bib754","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2147\/COPD.S428391","article-title":"Can treatable traits be the approach to addressing the complexity and heterogeneity of COPD?","volume":"18","author":"Cazzola","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib755","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pccm.2024.08.007","article-title":"Unveiling mechanisms of lung aging in COPD: a promising target for therapeutics development","volume":"2","author":"Devulder","year":"2024","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100124_bib756","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1183\/09031936.00168313","article-title":"Bronchodilator combinations for COPD: real hopes or a new Pandora\u2019s box?","volume":"42","author":"Roche","year":"2013","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100124_bib757","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1007\/s11033-014-3345-9","article-title":"Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis","volume":"41","author":"Wu","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.pharmr.2026.100124_bib758","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.micpath.2017.10.021","article-title":"Worldwide prevalence of viral infection in AECOPD patients: a meta-analysis","volume":"113","author":"Jafarinejad","year":"2017","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib759","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12931-022-02123-5","article-title":"Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review","volume":"23","author":"Hurst","year":"2022","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib760","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/rccm.201605-1014OC","article-title":"Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease","volume":"195","author":"Dransfield","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib761","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.stemcr.2016.09.010","article-title":"Rare SOX2+ airway progenitor cells generate KRT5+ cells that repopulate damaged alveolar parenchyma following influenza virus infection","volume":"7","author":"Ray","year":"2016","journal-title":"Stem Cell Rep"},{"issue":"7536","key":"10.1016\/j.pharmr.2026.100124_bib762","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nature14112","article-title":"Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury","volume":"517","author":"Vaughan","year":"2015","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100124_bib763","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1111\/bph.15621","article-title":"Lung pharmacokinetics of inhaled and systemic drugs: a clinical evaluation","volume":"178","author":"Sadiq","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100124_bib764","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.healun.2009.02.001","article-title":"Efficacy of a new pulmonary cyclosporine a powder formulation for prevention of transplant rejection in rats","volume":"28","author":"Zijlstra","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib765","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/acsinfecdis.5b00127","article-title":"Bedaquiline and pyrazinamide treatment responses are affected by pulmonary lesion heterogeneity in mycobacterium tuberculosis infected C3HeB\/FeJ mice","volume":"2","author":"Irwin","year":"2016","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib766","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/pharmrev.120.000108","article-title":"Inhaled medicines: past, present, and future","volume":"74","author":"Anderson","year":"2022","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib767","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1021\/acs.molpharmaceut.4c01534","article-title":"iBCS: 4. Application of the inhalation biopharmaceutics classification system to the development of orally inhaled drug products","volume":"22","author":"Forbes","year":"2025","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2026.100124_bib768","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2021.03.003","article-title":"Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations","volume":"173","author":"Thakral","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib769","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1021\/mp500423z","article-title":"Size and molecular flexibility of sugars determine the storage stability of freeze-dried proteins","volume":"12","author":"Tonnis","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2026.100124_bib770","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejpb.2017.01.024","article-title":"How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions","volume":"114","author":"Mensink","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib771","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43556-020-00014-z","article-title":"Developing inhaled protein therapeutics for lung diseases","volume":"1","author":"Matthews","year":"2020","journal-title":"Mol Biomed"},{"key":"10.1016\/j.pharmr.2026.100124_bib772","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114530","article-title":"Formulation strategies, preparation methods, and devices for pulmonary delivery of biologics","volume":"204","author":"Berkenfeld","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100124_bib773","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","article-title":"The lungs as a portal of entry for systemic drug delivery","volume":"1","author":"Patton","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pharmr.2026.100124_bib774","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115461","article-title":"Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids","volume":"215","author":"Bader","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100124_bib775","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/17425247.2022.2131767","article-title":"Are inhaled mRNA vaccines safe and effective? A review of preclinical studies","volume":"19","author":"Jansen","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib776","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/pharmaceutics16030347","article-title":"State-of-the-art review on inhalable lipid and polymer nanocarriers: design and development perspectives","volume":"16","author":"Costabile","year":"2024","journal-title":"Pharmaceutics"},{"issue":"732","key":"10.1016\/j.pharmr.2026.100124_bib777","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg6229","article-title":"TGF-\u03b2R2 signaling coordinates pulmonary vascular repair after viral injury in mice and human tissue","volume":"16","author":"Zhao","year":"2024","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100124_bib778","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-025-56448-y","article-title":"Targeted delivery of TGF-\u03b2 mRNA to murine lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers","volume":"16","author":"Meshanni","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100124_bib779","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124248","article-title":"A review on micro and nanoengineering in powder-based pulmonary drug delivery","volume":"659","author":"Pasero","year":"2024","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100124_bib780","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00921-2024","article-title":"COPD-iNET: a call to the lung community for action to combat the global epidemic of COPD","volume":"64","author":"Yildirim","year":"2024","journal-title":"Eur Respir J"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:41:20Z","timestamp":1779446480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":777,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0031699726000128"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100124","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regenerative therapeutics for chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100124"}}